Would you like to make this site your homepage? It's fast and easy...
Yes, Please make this my home page!
This page is still under construction.
Please return for more
complete information in the future. |
|---|
Back to home page.
|
Active Index To Abstracts |
|---|
To View Available Abstracts Or Excerpts
Click On The Word Abstract
Or Excerpt
Below Each Reference
1a. Water disinfection for international and
wilderness travelers.
Backer H
Clin Infect Dis. 2002 Feb 1;34(3):355-64
1b. A Possible Solution to the Malaria Problem?
Humble J
Libertarian Times, May 9, 2005
1c. The Miracle Mineral Supplement of the 21st Century.
Humble JV
www.miraclemineral.org, 2nd Edition (2007)
2a. The Miracle Mineral Supplement of the 21st Century.
Humble JV
www.miraclemineral.org, 2nd Edition (2007)
2b. personal communications from Mr. Jim Humble 2007
3a. Current status of malaria control.
Tripathi RP, Mishra RC, Dwivedi N, Tewari N, Verma SS
Curr Med Chem. 2005;12(22):2643-59
3b. Current status and progresses made in malaria chemotherapy.
Linares GE, Rodriguez JB
Curr Med Chem. 2007;14(3):289-314
3c. [various articles]
JAMA May23/30,2007 297(20)
3d. Malaria - Stopping a Global Killer.
Bedlam in the Blood - Malaria.
Finkel M, Stanmeyer J
National Geographic, Jul 2007, pp32-67
3e. An overview of chemotherapeutic targets
for antimalarial drug discovery.
Olliaro PL, Yuthavong Y
Pharmacol Ther. 1999 Feb;81(2):91-110
Abstract
4a. Chlorine Oxygen Acids and Salts: Chlorine Dioxide.
Robson HL
Kirk-Othmer Encyclopedia of Chemical Technology, Vol 5,
John Wiley & Sons, Inc. 2nd Ed. 1964 pp35-50
4b. The Chemistry of Chlorine Dioxide.
Gordon G, Kieffer RG, Rosenblatt DH
Progress in Inorganic Chemistry, Vol 15,
John Wiley & Sons, Inc. 1972 pp 201-286
4c. From Laboratory Curiosity to Heavy Chemical.
Rapson WH
Chemistry in Canada, 18:25-31, 1966
4d. Chlorine Dioxide: Chemical and Physical Properties.
Rosenblatt DH pp 332-343 in:
Ozone/Chlorine Dioxide Oxidation Products of Organic Materials.
Rice RG, Cotruvo JA editors,
International Ozone Institute & USEPA,
Ozone Press International, 1978
4e. Chlorine Dioxide: An Overview of its Preparation,
Properties and Uses
Gall RJ pp 356-382 in:
Ozone/Chlorine Dioxide Oxidation Products of Organic Materials.
Rice RG, Cotruvo JA editors,
International Ozone Institute & USEPA,
Ozone Press International, 1978
4f. Inorganic Chemistry.
Thorne PCL, Roberts ER
pp 368-371, 386-388
Interscience Publishers, Inc. 1949
4g. Introduction To Advanced Inorganic Chemistry.
Durrant PJ, Durrant B
pp 937-942
John Wiley & Sons, Inc.
4h. Advanced Inorganic Chemistry - A Comprehensive Text.
Cotton FA, Wilkinson G
pp 473-478
Interscience Publishers,
4i. Introduction to Inorganic Chemistry.
Brown GI
pp 292-295
Longman
4j. Inorganic Chemistry An Advanced Textbook.
Moeller T
pp 432-433,438-443
John Wiley & Sons, Inc.
4k. Inorganic Chemistry A Guide To Advanced Study. 3rd Ed.
Heslop RB, Robinson PL
pp 528-533
Elsevier Publishing Company, 1967,
4L. Concepts and Models of Inorganic Chemistry.
Douglas BE, McDaniel DH
pp 191-192
Blaisdell Publishing Company
4m. Encyclopedia of Science and Technology.
article regarding "chlorine"
p 99
McGraw-Hill
4n. The Chemical Elements And Their Compounds. Volume II.
Sidgwick NV
pp 1202-1207, 1224-1225
Oxford At The Clarendon Press
4o. Van Nostrand's Encyclopedia of Chemistry. 5th Edition.
Considine GD
article regarding "chlorine"
pp 371-372
Wiley-Interscience
4p. Inorganic Chemistry
Sharpe AG
pp 419-423
Longman Scientific & Technical
4q. Concise Inorganic Chemistry. 4th Edition.
Lee JD
pp 609-620
Chapman & Hall
4r. Comparative Inorganic Chemistry. 3rd Edition.
Moody B
pp 409-411,416,433-439
Edward Arnold
4s. The Chemistry of the Non-Metals
Jolly WL
pp 38-40
Prentice-Hall, Inc.
4t. Alternative Disinfectants and Oxidants
EPA Guidance Manual, April 1999,
4.1 Chlorine Dioxide Chemistry, pp 4-1 to 4-13
4u. Oxidation of Formaldehyde by Chlorite
in Basic and Slightly Acidic Media.
Chinake C, Olojo O, Simoyi RH
J Phys Chem A, 102 (3), 606-611, 1998
4v. General-Acid-Catalyzed Reactions of Hypochlorous Acid
and Acetyl Hypochlorite with Chlorite Ion.
Zhongjiang Jia, Dale W. Margerum,* and Joseph S. Francisco
Department of Chemistry, Purdue University, West Lafayette,
Indiana 47907 Received December 28, 1999
4w. Disproportionation of Chlorous Acid at a Strong Acidity.
Ni Y, Yin G
Ind Eng Chem Res, 1998, 37(6):2367-2372
4x. Kinetics and mechanism of chloride based chlorine
dioxide generation process from acidic sodium chlorate.
Deshwal BR, Lee HK
J Hazard Mater. 2004 May 20;108(3):173-82
4y. New pathways for chlorine dioxide decomposition
in basic solution.
Odeh IN, Francisco JS, Margerum DW
Inorg Chem. 2002 Dec 2;41(24):6500-6
4z. Kinetics and mechanisms of aqueous chlorine reactions
with chlorite ion in the presence of chloride ion and
acetic acid/acetate buffer.
Nicoson JS, Margerum DW
Inorg Chem. 2002 Jan 28;41(2):342-7
4aa. Kinetics and mechanism of catalytic decomposition and
oxidation of chlorine dioxide by the hypochlorite ion.
Csordy V, Bubnis B, FyyI, Gordon G
Inorg Chem. 2001 Apr 9;40(8):1833-6
4bb. General-acid-catalyzed reactions of hypochlorous acid
and acetyl hypochlorite with chlorite ion.
Jia Z, Margerum DW, Francisco JS
Inorg Chem. 2000 Jun 12;39(12):2614-20
4cc. Mechanism of Chlorine Dioxide and Chlorate Ion Formation
from the Reaction of Hypobromous Acid and Chlorite Ion.
Furman CS, Margerum DW
Inorg Chem. 1998 Aug 24;37(17):4321-4327
4dd. The Three-Electron Bond in Chlorine Dioxide.
Brockway LO
Proc Natl Acad Sci U S A. 1933 Mar;19(3):303-7
4ee. Toxicological Review of Chlorine Dioxide and Chlorite.
Integrated Risk Information System,
EPA/635/R-00/007, September 2000
4ff. Toxicological Profile for Chlorine Dioxide and Chlorite.
Agency for Toxic Substances and Disease Registry,
US Dept. Health and Human Services, September 2004
4gg. Technical note the pattern of ClO2 stabilized
by Na2CO3/H2O2.
Junli H, Lihua C, Zhenye Z
Water Res. 2001 Jul;35(10):2570-3
4hh. Control effects of p(epsilon) and pH on the
generation and stability of chlorine dioxide.
Pei YS, Wu XQ, Luan ZK, Wang T
J Environ Sci (China). 2003 Sep;15(5):680-4
5a. O2xygen Therapies - A New Way Of Approching Disease.
McCabe E, 1988,
Energy Publication
5b. Oxygen Healing Therapies - For Optimum Health And Vitality,
Altman N, 1995,
Healing Arts Press
5c. The Use Of Ozone In Medicine,
Rilling S, Viebahn R, (1985/1987/1994)
Haug Publishers
5d. Biologically Closed Electric Circuits,
Nordenstrom BEW, 1983,
Nordic Medical Publications
5e. Regional Intra-Arterial Hydrogen Peroxide Infusion And
Irradiation In The Treatment Of Head And Neck Malignancies:
A Progress Report.
Mallams JT, Balla GA, Finney JW
Trans Am Acad Ophthalmol Otolaryngol, 1963, Jul-Aug, 67:546-53
5f. War Against Microbes.
Bradford Research Institute
The Choice 28(2), 2001
5g. Chronic Fatigue Syndrome.
Rodriguez R
Consumer Health Organization of Canada. 1994 Apr;17(4)
5h. O2O2O2 - Oxygen Oxygen Oxygen -
Hydrogen Peroxide Magnesium Peroxide Chlorine Peroxide.
Donsbach KW, 1991,
Wholistic Publications
6a. Decreased level of 2,3-diphosphoglycerate and
alteration of structural integrity in erythrocytes
infected with Plasmodium falciparum in vitro.
Dubey ML, Hegde R, Ganguly NK, Mahajan RC
Mol Cell Biochem. 2003 Apr;246(1-2):137-41
6b. Changes in haemoglobin binding curve and oxygen
transport in chronic hypoxic lung disease.
Flenley DC, Fairweather LJ, Cooke NJ, Kirby BJ
Br Med J. 1975 Mar 15;1(5958):602-4
6c. Glycolysis in human erythrocytes containing elevated
concentrations of 2, 3-P2-glycerate.
Duhm J
Biochim Biophys Acta. 1975 Mar 14;385(1):68-80
6d. Oxygen-hemoglobulin dissociation curves:
effect of inherited enzyme defects of the red cell.
Delivoria-Papadopoulos M, Oski FA, Gottlieb AJ
Science. 1969 Aug 8;165(893):601-2
7a. Hyperbaric oxygen therapy:
using HBO therapy to increase circulation,
repair damaged tissue, fight infection, save limbs,
relieve pain, and more.
Neubauer RA, Walker M
Avery Publishing Group, Garden City Park, NY (1998)
7b. Textbook of Hyperbaric Medicine.
Jain KK, Neubauer RA, et al
Hogrefe & Huber Publishing, (October 2004)
7c. The Oxygen Revolution - Hyperbaric Oxygen Therapy:
the Groundbreaking New Treatment for: ...
Harch P, McCullough V, Duncan WA
Hatherleigh Press, (April 24, 2007)
7d. Hyperbaric Medicine Practice.
Kindwall EP, Whelan HT
Best Publishing Company, Flagstaff, AZ (1999)
8a. Survival Factor in Neoplastic and Viral Diseases.
Koch WF, 1961, Rio De Janeiro, Brazil,
Vanderkloot Press, Detroit, Michigan
8b. Hydrogen Peroxide Medical Miracle.
Douglass WC, 1996,
Second Opinion Publ Inc, Atlanta, GA
8c. Influenzal Pneumonia:
The Intravenous Injection Of Hydrogen Peroxide.
Oliver TH, Cantar BC, Murphy DV
The Lancet, 02-21-1920, pp 432-433
8d. Chlorite-hemoprotein interaction as key role for the
pharmacological activity of the chlorite-based drug WF10.
Schempp H, Reim M, Dornisch K, Elstner EF
Arzneimittelforschung. 2001;51(7):554-62
8e. Differential effects on innate versus
adaptive immune responses by WF10.
Giese T, McGrath MS, Stumm S, Schempp H, Elstner E,
Meuer SC
Cell Immunol. 2004 Jun;229(2):149-58
8f. Development of WF10, a novel macrophage-regulating agent.
McGrath MS, Kahn JO, Herndier BG
Curr Opin Investig Drugs. 2002 Mar;3(3):365-73
8g. Balanced macrophage activation hypothesis:
a biological model for development of drugs targeted
at macrophage functional states.
McGrath MS, Kodelja V
Pathobiology. 1999;67(5-6):277-81
8h. Randomized, double-blind, placebo-controlled trial
of the immune modulator WF10 in patients with advanced AIDS.
Raffanti SP, Schaffner W, Federspiel CF, Blackwell RB,
Ching OA, Kuhne FW
Infection. 1998 Jul-Aug;26(4):202-7
8i. Into the Light.
Douglass WC, 1997,
Second Opinion Publishing Inc, Atlanta, GA
8j. Redox regulation of NF-kappa B activation.
Flohe L, Brigelius-Flohe R, Saliou C, Traber MG, Packer L
Free Radic Biol Med 1997;22(6):1115-26
8k. The role of nuclear factor-kappa B in cytokine gene
regulation.
Blackwell TS, Christman JW
Am J Respir Cell Mol Biol 1997 Jul;17(1):3-9
8L. Transcription factors as activators of gene transcription:
AP-1 and NF-kappa B.
Adcock IM
Monaldi Arch Chest Dis 1997 Apr;52(2):178-86
8m. Regulation of the transcription factors NF-kappa B and
AP-1 by redox changes.
Meyer M, Pahl HL, Baeuerle PA
Chem Biol Interact 1994 Jun;91(2-3):91-100
8n. Modulation of transcription factor NF-kappa B binding
activity by oxidation-reduction in vitro.
Toledano MB, Leonard WJ
Proc Natl Acad Sci U S A 1991 May 15;88(10):4328-32
8o. Distinct effects of glutathione disulphide on the nuclear
transcription factor kappa B and the activator protein-1.
Galter D, Mihm S, Droge W
Eur J Biochem 1994 Apr 15;221(2):639-48
8p. Nuclear factor kappa B: an oxidative stress-responsive
transcription factor of eukaryotic cells (a review).
Schreck R, Albermann K, Baeuerle PA
Free Radic Res Commun 1992;17(4):221-37
8q. Functions of glutathione and glutathione disulfide
in immunology and immunopathology.
Droge W, Schulze-Osthoff K, Mihm S, Galter D, et al
FASEB J 1994 Nov;8(14):1131-8
8r. Modulation of monocyte chemokine production
and nuclear factor kappa B activity by oxidants.
Lee JS, Kahlon SS, Culbreth R, Cooper AD
J Interferon Cytokine Res 1999 Jul;19(7):761-7B
8s. Intracellular glutathione redox status modulates MCP-1
expression in pulmonary granulomatous vasculitis.
Desai A, Huang X, Warren JS
Lab Invest 1999 Jul;79(7):837-47
8t. Nuclear factor kappa B: a pivotal role in the systemic
inflammatory response syndrome and new target for therapy.
Christman JW, Lancaster LH, Blackwell TS
Intensive Care Med 1998 Nov;24(11):1131-8
Comment in: Intensive Care Med 1998 Nov;24(11):1129-30
8u. Differential regulation of extracellular signal-regulated
kinase and nuclear factor-kappa B signal transduction pathways
by hydrogen peroxide and tumor necrosis factor.
Milligan SA, Owens MW, Grisham MB
Arch Biochem Biophys 1998 Apr 15;352(2):255-62
8v. Hydrogen peroxide as a potent activator
of T lymphocyte functions.
Los M, Dröge W, Stricker K, Baeuerle PA, Schulze-Osthoff K
Eur J Immunol 1995 Jan; 25(1):159-65
9a. Hydrogen Peroxide in Human Blood.
Varma SD, Devamanoharan PS
Free Radic Res Commun. 1991;14(2):125-31
9b. Histochemical demonstration of hydrogen peroxide
production by leukocytes in fixed-frozen tissue sections
of inflammatory lesions.
Dannenberg AM Jr, Schofield BH, Rao JB, Dinh TT, Lee K,
Boulay M, Abe Y, Tsuruta J, Steinbeck MJ
J Leukoc Biol. 1994 Oct;56(4):436-43
9c. Interferon-gamma activates the oxidative killing
of Candida albicans by human granulocytes.
Stevenhagen A, van Furth R
Clin Exp Immunol. 1993 Jan;91(1):170-5
9d. Hydrogen peroxide production by alveolar type II cells,
alveolar macrophages, and endothelial cells.
Kinnula VL, Everitt JI, Whorton AR, Crapo JD
Am J Physiol. 1991 Aug;261(2 Pt 1):L84-91
9e. Stimulation of the respiratory burst and promotion
of bacterial killing in human granulocytes
by intravenous immunoglobulin preparations.
Marodi L, Kalmar A, Karmazsin L
Clin Exp Immunol. 1990 Feb;79(2):164-9
9f. Neutrophils may directly synthesize both H2O2 and O2- since
surface stimuli induce their release in stimulus-specific ratios.
Hoffstein ST, Gennaro DE, Manzi RM
Inflammation. 1985 Dec;9(4):425-37
9g. Quantitative and temporal characterization of the
extracellular H2O2 pool generated by human neutrophils.
Test ST, Weiss SJ
J Biol Chem. 1984 Jan 10;259(1):399-405
9h. Hydrogen peroxide release from eosinophils: quantitative,
comparative studies of human and guinea pig eosinophils.
Pincus SH
J Invest Dermatol. 1983 Apr;80(4):278-81
9i. Pyridine nucleotide-dependent generation of hydrogen peroxide
by a particulate fraction from human neutrophils.
DeChatelet LR, Shirley PS
J Immunol. 1981 Mar;126(3):1165-9
9j. Comparative studies on alveolar macrophages
and polymorphonuclear leukocytes. I. H2O2 and O2-
generation by rabbit alveolar macrophages.
Yamaguchi T, Kakinuma K, Kaneda M, Shimada K
J Biochem (Tokyo). 1980 May;87(5):1449-55
9k. Interrelationship between oxygen consumption,
superoxide anion and hydrogen peroxide formation
in phagocytosing guinea pig polymorphonuclear leucocytes.
Dri P, Bellavite P, Berton G, Rossi F
Mol Cell Biochem. 1979 Jan 26;23(2):109-22
9L. Hydrogen peroxide production and killing of Staphylococcus
aureus by human polymorphonuclear leukocytes.
Tsan MF, Douglass KH, McIntyre PA
Blood. 1977 Mar;49(3):437-44
9m. The role of superoxide anion and hydrogen peroxide
in phagocytosis-associated oxidative metabolic reactions.
Baehner RL, Murrmann SK, Davis J, Johnston RB Jr
J Clin Invest. 1975 Sep;56(3):571-6
9n. H2O2 release from human granulocytes during phagocytosis.
I. Documentation, quantitation, and some regulating factors.
Root RK, Metcalf J, Oshino N, Chance B
J Clin Invest. 1975 May;55(5):945-55
9o. Production of hydrogen peroxide
by phagocytizing human granulocytes.
Homan-Muller JW, Weening RS, Roos D
J Lab Clin Med. 1975 Feb;85(2):198-207
9p. Singlet excited oxygen as a mediator
of the antibacterial action of leukocytes.
Krinsky NI
Science. 1974 Oct 25;186(4161):363-5
9q. Biological defense mechanisms. The production
by leukocytes of superoxide, a potential bactericidal agent.
Babior BM, Kipnes RS, Curnutte JT
J Clin Invest. 1973 Mar;52(3):741-4
9r. The H2O2-production by polymorphonuclear
leukocytes during phagocytosis.
Zatti M, Rossi F, Patriarca P
Experientia. 1968 Jul 15;24(7):669-70
9s. A new method for the detection of hydroxyl radical
production by phagocytic cells.
Sagone AL Jr, Decker MA, Wells RM, Democko C
Biochim Biophys Acta. 1980 Feb 21;628(1):90-7
9t. Human granulocyte generation of hydroxyl radical.
Weiss SJ, Rustagi PK, LoBuglio AF
J Exp Med. 1978 Feb 1;147(2):316-23
9u. Production of singlet oxygen by eosinophils activated
in vitro by C5a and leukotriene B4.
Teixeira MM, Cunha FQ, Noronha-Dutra A, Hothersall J
FEBS Lett. 1999 Jun 25;453(3):265-8
9v. Investigating antibody-catalyzed ozone generation
by human neutrophils.
Babior BM, Takeuchi C, Ruedi J, Gutierrez A, Wentworth P
PNAS, Mar 18, 2003, 100(6):3031-3034
10a. Free radicals generation by granulocytes
from men during bed rest.
Pawlak W, Kedziora J, Zolynski K, Kedziora-Kornatowska
K, Blaszczyk J, Witkowski P
J Gravit Physiol. 1998 Jul;5(1):P131-2
10b. Eosinophils are a major source of nitric oxide-derived
oxidants in severe asthma: characterization of pathways
available to eosinophils for generating reactive
nitrogen species.
MacPherson JC, Comhair SA, Erzurum SC, Klein DF,
Lipscomb MF, Kavuru MS, Samoszuk MK, Hazen SL
J Immunol. 2001 May 1;166(9):5763-72
10c. Helicobacter pylori urease suppresses bactericidal
activity of peroxynitrite via carbon dioxide production.
Kuwahara H, Miyamoto Y, Akaike T, Kubota T, Sawa T,
Okamoto S, Maeda H
Infect Immun. 2000 Aug;68(8):4378-83
10d. Kinetics of nitric oxide and hydrogen peroxide
production and formation of peroxynitrite during
the respiratory burst of human neutrophils.
Carreras MC, Pargament GA, Catz SD, Poderoso JJ,
Boveris A
FEBS Lett. 1994 Mar 14;341(1):65-8
10e. Biological aspects of reactive nitrogen species.
Patel RP, McAndrew J, Sellak H, White CR, Jo H,
Freeman BA, Darley-Usmar VM
Biochim Biophys Acta. 1999 May 5;1411(2-3):385-400
10f. Peroxynitrite production by human neutrophils,
monocytes and lymphocytes challenged with lipopolysaccharide.
Gagnon C, Leblond FA, Filep JG
FEBS Lett. 1998 Jul 10;431(1):107-10
10g. Superoxide and peroxynitrite generation
from inducible nitric oxide synthase in macrophages.
Xia Y, Zweier JL
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6954-8
10h. Peroxynitrite formation from activated human leukocytes.
Fukuyama N, Ichimori K, Su Z, Ishida H, Nakazawa H
Biochem Biophys Res Commun. 1996 Jul 16;224(2):414-9
11a. Chlorination of Taurine by Human Neutrophils -
Evidence for Hypochlorous Acid Generation.
Weiss SJ, Klein R, Slivka A, Wei M
J Clin Invest, Sep 1982, 70:598-607
11b. Role of myeloperoxidase in the respiratory burst
of human neutrophils.
Nauseef WM, Metcalf JA, Root RK
Blood. 1983 Mar;61(3):483-92
11c. Role of myeloperoxidase-mediated antimicrobial
systems in intact leukocytes.
Klebanoff SJ, Hamon CB
J Reticuloendothel Soc. 1972 Aug;12(2):170-96
12a. Human mononuclear phagocyte antiprotozoal mechanisms:
oxygen-dependent vs oxygen-independent activity
against intracellular Toxoplasma gondii.
Murray HW, Rubin BY, Carriero SM, Harris AM, Jaffee EA
J Immunol. 1985 Mar;134(3):1982-8
12b. Phagocytosis and killing of the protozoan Leishmania
donovani by human polymorphonuclear leukocytes.
Pearson RD, Steigbigel RT
J Immunol. 1981 Oct;127(4):1438-43
12c. The role of the phagocyte in host-parasite interactions.
The direct quantitative estimation of H2O2 in phagocytizing cells.
Paul B, Sbarra AJ
Biochim Biophys Acta. 1968 Feb 1;156(1):168-78
13a. Oxidation-Reduction Potentials In Bacteriology And
Biochemistry.
L F Hewitt, 6th Ed, E. & S. Livingston Ltd., 1950
13b. Role of Oxidants in Microbial Pathophysiology.
R A Miller, B E Britigan
Clinical Microbiology Reviews, 10(1):1-18, Jan 1997
13c. Antiseptics and Disinfectants: Activity, Action and Resistance.
by G McDonnell & A D Russell
Clinical Microbiology Reviews, pp 147-179, Jan 1999
13d. Treatment with oxidizing agents damages the inner
membrane of spores of Bacillus subtilis and sensitizes
spores to subsequent stress.
Cortezzo DE, Koziol-Dube K, Setlow B, Setlow P
J Appl Microbiol. 2004;97(4):838-52
14a. Mechanisms of killing of Bacillus subtilis spores
by hypochlorite and chlorine dioxide.
Young SB, Setlow P.
J Appl Microbiol. 2003;95(1):54-67
14b. Inactivation of bacteria by Purogene.
Harakeh S, Illescas A, Matin A.
J Appl Bacteriol. 1988 May;64(5):459-63
14c. The inhibitory effect of Alcide, an antimicrobial drug,
on protein synthesis in Escherichia coli.
Scatina J, Abdel-Rahman MS, Goldman E.
J Appl Toxicol. 1985 Dec;5(6):388-94
14d. Bactericidal properties of chlorine dioxide.
Ridenour GM, Ingols RS
J Am Water Works Assn, 1947 39:561-567
14e. Bactericidal effects of chlorine dioxide.
Ridenour GM, Armbruster EH
J Am Water Works Assn, 1949 41:537-550
14f. Sporicidal properties of chlorine dioxide.
Ridenour GM, Ingols RS, Armbruster EH
Water & Sewage Works, 1949 96(8):1
14g. Efficacy of chlorine dioxide as a bacteriocide.
Bernarde MA, Isreal BM, Olivieri VP, Granstrom ML
Appl Microbiol, 1965, 13(5):776-780
14h. Kinetics and mechanism of bacterial disinfection
by chlorine dioxide.
Bernarde MA, Snow WB, Olivieri VP, Davidson B
Appl Microbiol, 1967, 15(2):257-265
14i. Alternative Disinfectants and Oxidants
EPA Guidance Manual, April 1999,
4.4 Pathogen Inactivation and Disinfection Efficacy,
pp 4-15 to 4-22
14j. Evaluation of ultrasonic scaling unit waterline
contamination after use of chlorine dioxide mouthrinse
lavage.
Wirthlin MR, Marshall GW JR
J Periodontol. 2001 Mar;72(3):401-10
15a. Degradation of the Poliovirus 1 genome
by chlorine dioxide.
Simonet J, Gantzer C
J Appl Microbiol. 2006 Apr;100(4):862-70
15b. Inactivation of enteric adenovirus and feline
calicivirus by chlorine dioxide.
Thurston-Enriquez JA, Haas CN, Jacangelo J, Gerba CP
Appl Environ Microbiol. 2005 Jun;71(6):3100-5
15c. Mechanisms of inactivation of hepatitis A virus
in water by chlorine dioxide.
Li JW, Xin ZT, Wang XW, Zheng JL, Chao FH
Water Res. 2004 Mar;38(6):1514-9
15d. Virucidal efficacy of four new disinfectants.
Eleraky NZ, Potgieter LN, Kennedy MA
J Am Anim Hosp Assoc. 2002 May-Jun;38(3):231-4
15e. Chlorine dioxide sterilization of red blood cells
for transfusion, additional studies.
Rubinstein A, Chanh T, Rubinstein DB.
Int Conf AIDS. 1994 Aug 7-12; 10: 235 (abstract no. PB0953).
U.S.C. School of Medicine, Los Angeles
15f. Inactivation of human immunodeficiency virus by a
medical waste disposal process using chlorine dioxide.
Farr RW, Walton C
Infect Control Hosp Epidemiol. 1993 Sep;14(9):527-9
15g. Inactivation of human and simian rotaviruses
by chlorine dioxide.
Chen YS, Vaughn JM
Appl Environ Microbiol. 1990 May;56(5):1363-6
15h. Disinfecting capabilities of oxychlorine compounds.
Noss CI, Olivieri VP
Appl Environ Microbiol. 1985 Nov;50(5):1162-4
15i. Mechanisms of inactivation of poliovirus
by chlorine dioxide and iodine.
Alvarez ME, O'Brien RT
Appl Environ Microbiol. 1982 Nov;44(5):1064-71
15j. A comparison of the virucidal properties of chlorine,
chlorine dioxide, bromine chloride and iodine.
Taylor GR, Butler M
J Hyg (Lond). 1982 Oct;89(2):321-8
15k. Inactivation of Poliomyelitis Virus by "Free" Chlorine.
Ridennour GM, Ingols RS
Am J Pub Health, 1946, 36(6):639
15L. Alternative Disinfectants and Oxidants
EPA Guidance Manual, April 1999,
4.4 Pathogen Inactivation and Disinfection Efficacy,
pp 4-15 to 4-22
16a. Alternative Disinfectants and Oxidants
EPA Guidance Manual, April 1999,
4.4 Pathogen Inactivation and Disinfection Efficacy,
pp 4-15 to 4-22
16b. Cysticidal effect of chlorine dioxide on Giardia
intestinalis cysts.
Winiecka-Krusnell J, Linder E
Acta Trop. 1998 Jul 30;70(3):369-72
16c. Effects of ozone, chlorine dioxide, chlorine, and
monochloramine on Cryptosporidium parvum oocyst viability.
Korich DG, Mead JR, Madore MS, Sinclair NA, Sterling CR
Appl Environ Microbiol. 1990 May;56(5):1423-8
16d. The effect of 'Alcide' on 4 strains of rodent
coccidial oocysts.
Owen DG
Lab Anim. 1983 Oct;17(4):267-9
16e. Water Treatment and Pathogen Control -
Process Efficiency in Achieving Safe Drinking Water.
LeChevallier MW, Au KK
Section 3.3.3 Chlorine dioxide pp 52-54
World Health Organization, IWA Publishing, 2004
16f. Sequential inactivation of Cryptosporidium parvum
oocysts with chlorine dioxide followed by free chlorine
or monochloramine.
Corona-Vasquez B, Rennecker JL, Driedger AM, Mariñas BJ
Water Res. 2002 Jan;36(1):178-88
17a. Disinfectant efficacy of chlorite and
chlorine dioxide in drinking water biofilms.
Gagnon GA, Rand JL, O'leary KC, Rygel AC, Chauret C, Andrews RC
Water Research, 39(9):1809-17, May 2005
17b. Pure Water Handbook.
Osmonics, Inc. Minnetonka, Minnesota
17c. Use Of Chlorine Dioxide In Water And Wastewater Treatment.
Sussman S, Rauh JS pp 344-355 in:
Ozone/Chlorine Dioxide Oxidation Products of Organic Materials.
Rice RG, Cotruvo JA editors,
International Ozone Institute & USEPA,
Ozone Press International, 1978
17d. Disinfection: Water and Wastewater.
Johnson JD
Ann Arbor Science Publishers, Inc. 1975
17e. Chlorine dioxide in potable water treatment.
Dowling LT
Water Treat. & Exam. 1974, 23:190-204
17f. Generation and use of chlorine dioxide in water treatment.
Granstrom ML, Lee GF
J Am Water Works Assn, 1958, 50:1453-1466
17g. Use of chlorine dioxide to disinfect water supplies.
Augenstein HW
J Am Water Works Assn, 1974, 66(12):716-717
17h. Water Treatment and Pathogen Control -
Process Efficiency in Achieving Safe Drinking Water.
LeChevallier MW, Au KK
Section 3.3.3 Chlorine dioxide pp 52-54
World Health Organization, IWA Publishing, 2004
17i. Matching odour treatment processes to odour resources.
Jeavons J, Hodgson P, Upton J
Water Science and Technology, 2000, 41(9):227-232
17j. The effect of predisinfection with chlorine dioxide
on the formation of haloacetic acids and trihalomethanes
in a drinking water supply.
Harris CL
Thesis submitted to Virginia Polytechnic Institute and
State University, July 27,2001
17k. Effect of pH and temperature on the kinetics
of odor oxidation using chlorine dioxide.
Kastner JR, Das KC, Hu C, McClendon R
J Air Waste Manag Assoc. 2003 Oct;53(10):1218-24
17L. Development of chlorine dioxide-related by-product
models for drinking water treatment.
Korn C, Andrew RC, Escobar MD
Water Res. 2002 Jan;36(1):330-42
18a. Cadaverine as a putative component of oral malodor.
Goldberg S, Kozlovsky A, Gordon D, Gelernter I,
Sintov A, Rosenberg M
J Dent Res. 1994 Jun;73(6):1168-72
18b. A multifactorial investigation of the ability of oral
health care products (OHCPs) to alleviate oral malodour.
Silwood CJ, Grootveld MC, Lynch E
J Clin Periodontol. 2001 Jul;28(7):634-41
18c. Use of 0.1% chlorine dioxide to inhibit the formation
of morning volatile sulphur compounds (VSC).
Peruzzo DC, Jandiroba PF, Nogueira Filho Gda R
Braz Oral Res. 2007 Jan-Mar;21(1):70-4
18d. Use of chlorine dioxide mouthrinse
as the ultrasonic scaling lavage reduces
the viable bacteria in the generated aerosols.
Wirthlin MR, Choi JH, Kye SB
J West Soc Periodontol Periodontal Abstr. 2006;54(2):35-44
18e. Use of a novel group of oral malodor measurements
to evaluate an anti-oral malodor mouthrinse (TriOralTM)
in humans.
Codipilly DP, Kaufman HW, Kleinberg I
J Clin Dent. 2004;15(4):98-104
18f. The clinical and microbiological effects of a novel
acidified sodium chlorite mouthrinse on oral bacterial
mucosal infections.
Fernandes-Naglik L, Downes J, Shirlaw P, Wilson R,
Challacombe SJ, Kemp GK, Wade WG
Oral Dis. 2001 Sep;7(5):276-80
18g. Efficacy of a chlorine dioxide-containing
mouthrinse in oral malodor.
Frascella J, Gilbert RD, Fernandez P, Hendler J
Compend Contin Educ Dent. 2000 Mar;
21(3):241-4, 246, 248 passim; quiz 256
18h. Odor reduction potential
of a chlorine dioxide mouthrinse.
Frascella J, Gilbert R, Fernandez P
J Clin Dent. 1998;9(2):39-42
18i. Use of a metastabilized chlorous acid/chlorine dioxide
formulation as a mouthrinse for plaque reduction.
Goultschin J, Green J, Machtei E, Stabholz A, Brayer L,
Schwartz Z, Sela MN, Soskolne A
Isr J Dent Sci. 1989 Oct;2(3):142-7
19a. Use of chlorine dioxide for cannery sanitation and
water conservation.
Welch JL, Folinazzo JF
Food Technology, 1959, 13(3):179-182
20a. Effects of Carcass Washing Systems on Campylobacter
Contamination in Large Broiler Processing Plants
by M P Bashor,
Masters Thesis, North Carolina State University, Dec 2002
20b. Research Project Outline #4111,
by C N Cutter, Penn State Univ, Nov 2005
20c. Validation of the use of organic acids and acidified
sodium chlorite to reduce Escherichia coli O157 and
Salmonella typhimurium in beef trim and ground beef
in a simulated processing environment.
by Harris K, Miller MF, Loneragan GH, Brashears MM.
J Food Prot. 69(8):1802-7, Aug 2006
20d. Decreased dosage of acidified sodium chlorite reduces
microbial contamination and maintains organoleptic
qualities of ground beef products.
Bosilevac JM, Shackelford SD, Fahle R, Biela T, Koohmaraie M.
J Food Prot. 2004 Oct;67(10):2248-54
20e. The Evaluation of Antimicrobial Treatments for
Poultry Carcasses
European Commission Health & Consumer Protection Directorate-
General, April 2003
20f. Determination of chlorate and chlorite and mutagenicity
of seafood treated with aqueous chlorine dioxide.
Kim J, Marshall MR, Du WX, Otwell WS, Wei CI
J Agric Food Chem. 1999 Sep;47(9):3586-91
20g. Acidified sodium chlorite solutions.
Food and Drug Administration, HHS, pp143-144,
Section 173.325, 21CFR Ch.1 (4-1-07 Edition)
21a. Review - Application of Acidified Sodium Chlorite
to Improve the Food Hygiene of Lightly Fermented Vegetables.
by Y Inatsu, L Bari, S Kawamoto
JARC 41(1 , pp 17-23, 2007
21b. Reactions of aqueous chlorine and chlorine dioxide
with model food compounds.
Fukayama MY, Tan H, Wheeler WB, Wei CI
Environ Health Perspect. 1986 Nov;69:267-74
22a. Efficacy of Two Barrier Teat Dips Containing Chlorous
Acid Germicides Against Experimental Challenge ...
by R L Boddie, S C Nickerson, G K Kemp
Journal of Dairy Science, 77 (10):3192-3197, 1994
22b. Evaluation of a Chlorous Experimental and Natural Acid
Chlorine Dioxide Teat Dip Under Experimental and Natural
Exposure Conditions
by P A Drechsler, E E Wildman, J W Pankey
Journal of Dairy Science, 73 (8):2121, 1990
22c. Preventing Bovine Mastitis by a Postmilking Teat
Disinfectant Containing Acidified Sodium Chlorite
by J E Hillerton, J Cooper, J Morelli
Journal of Dairy Science, 90:1201-1208, 2007
23a. Endoscope disinfection using chlorine dioxide
in an automated washer-disinfector.
Isomoto H, Urata M, Kawazoe K, Matsuda J, Nishi Y, Wada
A, Ohnita K, Hirakata Y, Matsuo N, Inoue K, Hirayama T,
Kamihira S, Kohno S
J Hosp Infect. 2006 Jul;63(3):298-305
24a. Clinical and microbiological efficacy of chlorine dioxide
in the management of chronic atrophic candidiasis: an open study.
Mohammad AR, Giannini PJ, Preshaw PM, Alliger H.
Int Dent J. 2004 Jun;54(3):154-8
24b. Using a chlorine dioxide antibacterial gel
for soft tissue healing.
Babad MS
Dent Today. 1999 Jun;18(6):88-9
24c. Subchronic dermal toxicity studies
of Alcide Allay gel and liquid in rabbits.
Abdel-Rahman MS, Skowronski GA, Turkall RM, Gerges SE,
Kadry AR, Abu-Hadeed AH
J Appl Toxicol. 1987 Oct;7(5):327-33
24d. Pharmacodynamics of alcide, a new antimicrobial
compound, in rat and rabbit.
Scatina J, Abdel-Rahman MS, Gerges SE, Khan MY, Gona O
Fundam Appl Toxicol. 1984 Jun;4(3 Pt 1):479-84
25a. Double-drug development against antioxidant enzymes
from Plasmodium falciparum.
Biot C, Dessolin J, Grellier P, Davioud-Charvet E
Redox Rep. 2003;8(5):280-3
25b. Oxidative stress and antioxidant defenses:
a target for the treatment of diseases caused
by parasitic protozoa.
Turrens JF
Mol Aspects Med. 2004 Feb-Apr;25(1-2):211-20
25c. Vampires, Pasteur and reactive oxygen species.
Is the switch from aerobic to anaerobic metabolism
a preventive antioxidant defence in blood-feeding
parasites?
Oliveira PL, Oliveira MF
FEBS Lett. 2002 Aug 14;525(1-3):3-6
25d. The role of cell-mediated immune responses
in resistance to malaria, with special reference
to oxidant stress.
Allison AC, Eugui EM
Annu Rev Immunol. 1983;1:361-92
25e. Thalassaemia trait, red blood cell age and oxidant
stress: effects on Plasmodium falciparum growth and
sensitivity to artemisinin.
Senok AC, Nelson EA, Li K, Oppenheimer SJ
Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):585-9
25f. Antiplasmodial activity of nitroaromatic and
quinoidal compounds: redox potential vs. inhibition
of erythrocyte glutathione reductase.
Grellier P, Sarlauskas J, Anusevicius Z, Maroziene A,
Houee-Levin C, Schrevel J, Cenas N
Arch Biochem Biophys. 2001 Sep 15;393(2):199-206
25g. Reactive oxygen and nitrogen intermediates and
products from polyamine degradation are Babesiacidal
in vitro.
Johnson WC, Cluff CW, Goff WL, Wyatt CR
Ann N Y Acad Sci. 1996 Jul 23;791:136-47
25h. Amine peroxides as potential antimalarials.
Vennerstrom JL
J Med Chem. 1989 Jan;32(1):64-7
25i. Thalassaemia trait, red blood cell age and oxidant
stress: effects on Plasmodium falciparum growth and
sensitivity to artemisinin.
Senok AC, Nelson EA, Li K, Oppenheimer SJ
Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):585-9
25j. Protection against murine cerebral malaria
by dietary-induced oxidative stress.
Levander OA, Fontela R, Morris VC, Ager AL Jr
J Parasitol. 1995 Feb;81(1):99-103
25k. Antioxidant defense mechanisms in parasitic protozoa.
Mehlotra RK
Crit Rev Microbiol. 1996;22(4):295-314
25L. Killing of Plasmodium yoelii by enzyme-induced
products of the oxidative burst.
Dockrell HM, Playfair JH
Infect Immun. 1984 Feb;43(2):451-6
25m. Toxicity of certain products of lipid peroxidation
to the human malaria parasite Plasmodium falciparum.
Clark IA, Butcher GA, Buffinton GD, Hunt NH, Cowden WB
Biochem Pharmacol. 1987 Feb 15;36(4):543-6
25n. Oxidative stress and malaria-infected erythrocytes.
Mishra NC, Kabilan L, Sharma A
Indian J Malariol. 1994 Jun;31(2):77-87
25o. Killing of blood-stage murine malaria parasites
by hydrogen peroxide.
Dockrell HM, Playfair JH
Infect Immun. 1983 Jan;39(1):456-9
25p. Evidence for reactive oxygen intermediates
causing hemolysis and parasite death in malaria.
Clark IA, Hunt NH
Infect Immun. 1983 Jan;39(1):1-6
26a. Mechanism-based design of parasite-targeted
artemisinin derivatives: synthesis and antimalarial activity
of new diamine containing analogues.
Hindley S, Ward SA, Storr RC, Searle NL, Bray PG, Park BK,
Davies J, O'Neill PM
J Med Chem. 2002 Feb 28;45(5):1052-63
26b. Proposed reductive metabolism of artemisinin
by glutathione transferases in vitro.
Mukanganyama S, Naik YS, Widersten M, Mannervik B,
Hasler JA
Free Radic Res. 2001 Oct;35(4):427-34
26c. Effect of dihydroartemisinin on the antioxidant
capacity of P. falciparum-infected erythrocytes.
Ittarat W, Sreepian A, Srisarin A, Pathepchotivong K
Southeast Asian J Trop Med Public Health. 2003 Dec;34(4):744-50
26d. Evidence that haem iron in the malaria parasite is
not needed for the antimalarial effects of artemisinin.
Parapini S, Basilico N, Mondani M, Olliaro P,
Taramelli D, Monti D
FEBS Lett. 2004 Sep 24;575(1-3):91-4
26e. Why artemisinin and certain synthetic peroxides are
potent antimalarials. Implications for the mode of action.
Jefford CW
Curr Med Chem. 2001 Dec;8(15):1803-26
26f. Redox reaction of artemisinin with ferrous
and ferric ions in aqueous buffer.
Sibmooh N, Udomsangpetch R, Kujoa A, Chantharaksri U,
Mankhetkorn S
Chem Pharm Bull (Tokyo). 2001 Dec;49(12):1541-6
26g. Artemisinin and the antimalarial endoperoxides:
from herbal remedy to targeted chemotherapy.
Meshnick SR, Taylor TE, Kamchonwongpaisan S
Microbiol Rev. 1996 Jun;60(2):301-15
26h. The mode of action of antimalarial endoperoxides.
Meshnick SR
Trans R Soc Trop Med Hyg. 1994 Jun;88 Suppl 1:S31
26i. Iron-dependent free radical generation from the
antimalarial agent artemisinin (qinghaosu).
Meshnick SR, Yang YZ, Lima V, Kuypers F,
Kamchonwongpaisan S, Yuthavong Y
Antimicrob Agents Chemother. 1993 May;37(5):1108-14
26j. Effect of beta-arteether treatment on erythrocytic
methemoglobin reductase system in Plasmodium yoelii
nigeriensis infected mice.
Srivastava S, Alhomida AS, Siddiqi NJ, Pandey VC, Puri SK
Drug Chem Toxicol. 2001 May;24(2):181-90
26k. In vitro assessment of methylene blue on chloroquine-
sensitive and -resistant Plasmodium falciparum strains
reveals synergistic action with artemisinins.
Akoachere M, Buchholz K, Fischer E, Burhenne J,
Haefeli WE, Schirmer RH, Becker K
Antimicrob Agents Chemother. 2005 Nov;49(11):4592-7
26L. Studies on hepatic oxidative stress and antioxidant
defence systems during arteether treatment of
Plasmodium yoelii nigeriensis infected mice.
Siddiqi NJ, Pandey VC
Mol Cell Biochem. 1999 Jun;196(1-2):169-73
26m. Effect of sodium artesunate on malaria infected human
erythrocytes.
Pan HZ, Lin FB, Zhang ZA
Proc Chin Acad Med Sci Peking Union Med Coll. 1989;4(4):181-5
26n. [Peroxidative antimalaria mechanism of sodium artesunate]
Li FB, Pan HZ [article in Chinese]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1989 Jun;11(3):180-4
27a. Radical-mediated damage to parasites and erythrocytes
in Plasmodium vinckei infected mice after injection
of t-butyl hydroperoxide.
Clark IA, Hunt NH, Cowden WB, Maxwell LE, Mackie EJ
Clin Exp Immunol. 1984 Jun;56(3):524-30
28a. Potentiation of an antimalarial oxidant drug.
Winter RW, Ignatushchenko M, Ogundahunsi OA,
Cornell KA, Oduola AM, Hinrichs DJ, Riscoe MK
Antimicrob Agents Chemother. 1997 Jul;41(7):1449-54
29a. The multiple roles of the mitochondrion
of the malarial parasite.
Krungkrai J
Parasitology. 2004 Nov;129(Pt 5):511-24
29b. Antimalarial quinones: redox potential dependence of
methemoglobin formation and heme release in erythrocytes.
Lopez-Shirley K, Zhang F, Gosser D, Scott M, Meshnick SR
J Lab Clin Med. 1994 Jan;123(1):126-30
29c. Antimalarial efficacy of methylene blue and
menadione and their effect on glutathione metabolism
of Plasmodium yoelii-infected albino mice.
Arora K, Srivastava AK
Parasitol Res. 2005 Dec;97(6):521-6
29d. Antiplasmodial activity of nitroaromatic and
quinoidal compounds: redox potential vs. inhibition
of erythrocyte glutathione reductase.
Grellier P, Sarlauskas J, Anusevicius Z, Maroziene A,
Houee-Levin C, Schrevel J, Cenas N
Arch Biochem Biophys. 2001 Sep 15;393(2):199-206
29e. Antiplasmodial activity of naphthoquinones related
to lapachol and beta-lapachone.
Pérez-Sacau E, Estévez-Braun A, Ravelo AG,
Gutiérrez Yapu D, Giménez Turba A
Chem Biodivers. 2005 Feb;2(2):264-74
29f. Newbouldiaquinone A: A naphthoquinone-anthraquinone
ether coupled pigment, as a potential antimicrobial and
antimalarial agent from Newbouldia laevis.
Eyong KO, Folefoc GN, Kuete V, Beng VP, Krohn K, Hussain H,
Nkengfack AE, Saeftel M, Sarite SR, Hoerauf A
Phytochemistry. 2006 Mar;67(6):605-9;Epub 2006 Jan 26
29g. Anthranoid compounds with antiprotozoal activity
from Vismia orientalis.
Mbwambo ZH, Apers S, Moshi MJ, Kapingu MC, Van Miert S,
Claeys M, Brun R, Cos P, Pieters L, Vlietinck A
Planta Med. 2004 Aug;70(8):706-10
29h. Antimalarial activity of phenazines from lapachol,
beta-lapachone and its derivatives against Plasmodium
falciparum in vitro and Plasmodium berghei in vivo.
de Andrade-Neto VF, Goulart MO, da Silva Filho JF,
da Silva MJ, Pinto Mdo C, Pinto AV, Zalis MG,
Carvalho LH, Krettli AU
Bioorg Med Chem Lett. 2004 Mar 8;14(5):1145-9
29i. In vitro antiprotozoal and cytotoxic activities
of some alkaloids, quinones, flavonoids, and coumarins.
del Rayo Camacho M, Phillipson JD, Croft SL, Yardley V,
Solis PN
Planta Med. 2004 Jan;70(1):70-2
29j. Aminonaphthoquinones--a novel class of compounds
with potent antimalarial activity against Plasmodium
falciparum.
Kapadia GJ, Azuine MA, Balasubramanian V, Sridhar R
Pharmacol Res. 2001 Apr;43(4):363-7
29k. In vitro response of Plasmodium falciparum to
atovaquone and correlation with other antimalarials:
comparison between African and Asian strains.
Gay F, Bustos D, Traore B, Jardinel C, Southammavong M,
Ciceron L, Danis MM
Am J Trop Med Hyg. 1997 Mar;56(3):315-7
29L. In vitro activity of natural and synthetic
naphthoquinones against erythrocytic stages
of Plasmodium falciparum.
Carvalho LH, Rocha EM, Raslan DS, Oliveira AB, Krettli AU
Braz J Med Biol Res. 1988;21(3):485-7
29m. Antiplasmodial and antioxidant isofuranonaphthoquinones
from the roots of Bulbine capitata.
Bezabih M, Abegaz BM, Dufall K, Croft K, Skinner-Adams T,
Davis TM
Planta Med. 2001 Jun;67(4):340-4
30a. Methylene blue as an antimalarial agent.
Schirmer RH, Coulibaly B, Stich A, Scheiwein M,
Merkle H, Eubel J, Becker K, Becher H, Müller O,
Zich T, Schiek W, Kouyaté B
Redox Rep. 2003;8(5):272-5
30b. Recombinant Plasmodium falciparum glutathione reductase
is inhibited by the antimalarial dye methylene blue.
Färber PM, Arscott LD, Williams CH Jr, Becker K,
Schirmer RH
FEBS Lett. 1998 Feb 6;422(3):311-4
30c. Antimalarial efficacy of methylene blue and
menadione and their effect on glutathione metabolism
of Plasmodium yoelii-infected albino mice.
Arora K, Srivastava AK
Parasitol Res. 2005 Dec;97(6):521-6
30d. Methylene blue for malaria in Africa: results from
a dose-finding study in combination with chloroquine
Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T,
Mansmann U, Rengelshausen J, Schiek W, Jahn A,
Walter-Sack I, Mikus G, Burhenne J, Riedel KD,
Schirmer RH, Kouyaté B, Müller O
Malar J. 2006;5:84
30e. In vitro assessment of methylene blue on chloroquine-
sensitive and -resistant Plasmodium falciparum strains
reveals synergistic action with artemisinins.
Akoachere M, Buchholz K, Fischer E, Burhenne J,
Haefeli WE, Schirmer RH, Becker K
Antimicrob Agents Chemother. 2005 Nov;49(11):4592-7
30f. Mode of antimalarial effect of methylene blue and
some of its analogues on Plasmodium falciparum in culture
and their inhibition of P. vinckei petteri and P.
yoelii nigeriensis in vivo.
Atamna H, Krugliak M, Shalmiev G, Deharo E,
Pescarmona G, Ginsburg H
Biochem Pharmacol. 1996 Mar 8;51(5):693-700
30g. Antimalarial dyes revisited: xanthenes, azines,
oxazines, and thiazines.
Vennerstrom JL, Makler MT, Angerhofer CK, Williams JA
Antimicrob Agents Chemother. 1995 Dec;39(12):2671-7
30h. The influence of methylene blue on the pentose
phosphate pathway in erythrocytes of monkeys infected
with Plasmodium knowlesi.
Barnes MG, Polet H
J Lab Clin Med. 1969 Jul;74(1):1-11
30i. The phenothiazinium chromophore and the evolution
of antimalarial drugs.
Wainwright M, Amaral L
Trop Med Int Health. 2005 Jun;10(6):501-11
31a. Thiol-based redox metabolism of protozoan parasites.
Muller S, Liebau E, Walter RD, Krauth-Siegel RL
Trends Parasitol. 2003 Jul;19(7):320-8
Comment in: Trends Parasitol. 2004 Feb;20(2):58-9
31b. Glutathione, altruistic metabolite in fungi.
Pócsi I, Prade RA, Penninckx MJ
Adv Microb Physiol. 2004;49:1-76
32a. A comparison of the effects of ocular preservatives
on mammalian and microbial ATP and glutathione levels.
Ingram PR, Pitt AR, Wilson CG, Olejnik O, Spickett CM
Free Radic Res. 2004 Jul;38(7):739-50
32b. The effect of Alcide, a new antimicrobial drug,
on rat blood glutathione and erythrocyte osmotic
fragility, in vitro.
Abdel-Rahman MS, Scatina J
J Appl Toxicol. 1985 Jun;5(3):178-81
32c. Chlorite-hemoprotein interaction as key role for the
pharmacological activity of the chlorite-based drug WF10.
Schempp H, Reim M, Dornisch K, Elstner EF
Arzneimittelforschung. 2001;51(7):554-62
32d. Kinetics and mechanisms of chlorine dioxide and
chlorite oxidations of cysteine and glutathione.
Ison A, Odeh IN, Margerum DW
Inorg Chem. 2006 Oct 16;45(21):8768-75
32e. The interaction of sodium chlorite with
phospholipids and glutathione: a comparison of effects
in vitro, in mammalian and in microbial cells.
Ingram PR, Homer NZ, Smith RA, Pitt AR, Wilson CG,
Olejnik O, Spickett CM
Arch Biochem Biophys. 2003 Feb 1;410(1):121-33
32f. Pharmacodynamics of alcide, a new antimicrobial
compound, in rat and rabbit.
Scatina J, Abdel-Rahman MS, Gerges SE, Khan MY, Gona O
Fundam Appl Toxicol. 1984 Jun;4(3 Pt 1):479-84
(decreased glutathion)
32g. Effect of chlorine dioxide and metabolites
on glutathione dependent system in rat, mouse and
chicken blood.
Couri D, Abdel-Rahman MS
J Environ Pathol Toxicol 1979 Dec;3(1-2):451-60
32h. Kinetics of Cl02 and effects of Cl02, Cl02-,
and Cl03- in drinking water on blood glutathione and
hemolysis in rat and chicken.
Abdel-Rahman MS, Couri D, Bull RJ
J Environ Pathol Toxicol. 1979 Dec;3(1-2):431-49
32i. Oxidative damage to the erythrocyte induced
by sodium chlorite, in vitro.
Heffernan WP, Guion C, Bull RJ
J Environ Pathol Toxicol. 1979 Jul-Aug;2(6):1501-10
(chlorite depletes GSH)
32j. Oxidative damage to the erythrocyte induced
by sodium chlorite, in vivo.
Heffernan WP, Guion C, Bull RJ
J Environ Pathol Toxicol. 1979 Jul-Aug;2(6):1487-99
(chlorite decreases GSH)
32k. The effect of Alcide, a new antimicrobial drug, on rat
blood glutathione and erythrocyte osmotic fragility, in vitro.
Abdel-Rahman MS, Scatina J
J Appl Toxicol. 1985 Jun;5(3):178-81
32L. Toxicity of chlorine dioxide in drinking water.
Abdel-Rahman MS, Couri D, Bull RJ
J Environ Pathol Toxicol Oncol. 1985 Sep-Oct;6(1):105-13
33a. Oxyhalogen-Sulfur Chemistry:
Kinetics and Mechanism of Oxidation of N-Acetylthiourea
by Chlorite and Chlorine Dioxide.
Olagunju O, Siegel PD, Olojo R, Simoyi RH
J Phys Chem A, 110 (7), 2396 -2410, 2006
33b. Oxyhalogen-Sulfur Chemistry:
Oxidation of N-Acetylcysteine
by Chlorite and Acidic Bromate.
Darkwa J, Olojo R, Olagunju O, Otoikhian A, Simoyi RH
J. Phys. Chem. A, 107 (46), 9834 -9845, 2003
33c. Oxyhalogen - Sulfur Chemistry:
Oxidation of Taurine by Chlorite in Acidic Medium
Chinake CR, Simoyi RH
J Phys Chem B, 1997, 101, 1207
34a. Thioredoxin networks in the malarial parasite
Plasmodium falciparum.
Nickel C, Rahlfs S, Deponte M, Koncarevic S, Becker K
Antioxid Redox Signal. 2006 Jul-Aug;8(7-8):1227-39
34b. Thioredoxin and glutathione system of malaria
parasite Plasmodium falciparum.
Muller S, Gilberger TW, Krnajski Z, Luersen K,
Meierjohann S, Walter RD, Muller S, Lüersen K
Protoplasma. 2001;217(1-3):43-9
34c. Plasmodium falciparum thioredoxins and glutaredoxins
as central players in redox metabolism.
Rahlfs S, Nickel C, Deponte M, Schirmer RH, Becker K
Redox Rep. 2003;8(5):246-50
34d. The thiol-based redox networks of pathogens:
unexploited targets in the search for new drugs.
Jaeger T, Flohe L, Flohé L
Biofactors. 2006;27(1-4):109-20
34e. Redox and antioxidant systems of the malaria parasite
Plasmodium falciparum.
Muller S
Mol Microbiol. 2004 Sep;53(5):1291-305
35a. The plasmodial apicoplast was retained under evolutionary
selective pressure to assuage blood stage oxidative stress.
Toler S
Med Hypotheses. 2005;65(4):683-90
35b. Scavenging of the cofactor lipoate is essential for the
survival of the malaria parasite Plasmodium falciparum
Allary M, Lu JZ, Zhu L, Prigge ST
Mol Microbiol. 2007 Mar;63(5):1331-44;Epub 2007 Jan 22
35c. Plasmodium falciparum possesses organelle-specific alpha-
keto acid dehydrogenase complexes and lipoylation pathways.
Günther S, McMillan PJ, Wallace LJ, Müller S
Biochem Soc Trans. 2005 Nov;33(Pt 5):977-80
35d. The malaria parasite Plasmodium falciparum has
only one pyruvate dehydrogenase complex, which is located
in the apicoplast.
Foth BJ, Stimmler LM, Handman E, Crabb BS, Hodder AN,
McFadden GI
Mol Microbiol. 2005 Jan;55(1):39-53
Comment in: Mol Microbiol. 2005 Jan;55(1):1-4
35e. The human malaria parasite Plasmodium falciparum
possesses two distinct dihydrolipoamide dehydrogenases.
McMillan PJ, Stimmler LM, Foth BJ, McFadden GI, Müller S
Mol Microbiol. 2005 Jan;55(1):27-38
Comment in: Mol Microbiol. 2005 Jan;55(1):1-4
35f. The human malaria parasite Plasmodium falciparum has
distinct organelle-specific lipoylation pathways.
Wrenger C, Müller S
Mol Microbiol. 2004 Jul;53(1):103-13
35g. Apicomplexan parasites contain a single lipoic acid
synthase located in the plastid.
Thomsen-Zieger N, Schachtner J, Seeber F
FEBS Lett. 2003 Jul 17;547(1-3):80-6
35h. Biosynthetic pathways of plastid-derived organelles
as potential drug targets against parasitic apicomplexa.
Seeber F
Curr Drug Targets Immune Endocr Metabol Disord.
2003 Jun;3(2):99-109
36a. Fatty acid biosynthesis as a drug target
in apicomplexan parasites.
Goodman CD, McFadden GI
Curr Drug Targets. 2007 Jan;8(1):15-30
36b. Apicoplast fatty acid biosynthesis as a target
for medical intervention in apicomplexan parasites.
Gornicki P
Int J Parasitol. 2003 Aug;33(9):885-96
36c. A type II pathway for fatty acid biosynthesis presents
drug targets in Plasmodium falciparum.
Waller RF, Ralph SA, Reed MB, Su V, Douglas JD,
Minnikin DE, Cowman AF, Besra GS, McFadden GI
Antimicrob Agents Chemother. 2003 Jan;47(1):297-301
36d. Recombinant expression and biochemical characterization
of the unique elongating beta-ketoacyl-acyl carrier protein
synthase involved in fatty acid biosynthesis of Plasmodium
falciparum using natural and artificial substrates
Lack G, Homberger-Zizzari E, Folkers G, Scapozza L, Perozzo R
J Biol Chem. 2006 Apr 7;281(14):9538-46
36e. Identification, characterization, and inhibition
of Plasmodium falciparum beta-hydroxyacyl-acyl carrier
protein dehydratase (FabZ).
Sharma SK, Kapoor M, Ramya TN, Kumar S, Kumar G, Modak R,
Sharma S, Surolia N, Surolia A
J Biol Chem. 2003 Nov 14;278(46):45661-71
36f. Analyses of co-operative transitions in Plasmodium
falciparum beta-ketoacyl acyl carrier protein reductase
upon co-factor and acyl carrier protein binding.
Karmodiya K, Surolia N
FEBS J. 2006 Sep;273(17):4093-103
37a. Characterization of the glyoxalases of the malarial parasite
Plasmodium falciparum and comparison with their human counterparts
Akoachere M, Iozef R, Rahlfs S, Deponte M, Mannervik B,
Creighton DJ, Schirmer H, Becker K
Biol Chem. 2005 Jan;386(1):41-52
37b. Glutathione--functions and metabolism in the malarial
parasite Plasmodium falciparum.
Becker K, Rahlfs S, Nickel C, Schirmer RH
Biol Chem. 2003 Apr;384(4):551-66
37c. The thioredoxin system of the malaria parasite
Plasmodium falciparum. Glutathione reduction revisited.
Kanzok SM, Schirmer RH, Turbachova I, Iozef R, Becker K
J Biol Chem. 2000 Dec 22;275(51):40180-6
37d. Thioredoxin and glutathione system of malaria
parasite Plasmodium falciparum.
Muller S, Gilberger TW, Krnajski Z, Luersen K,
Meierjohann S, Walter RD, Muller S, Lüersen K
Protoplasma. 2001;217(1-3):43-9
37e. Thioredoxin reductase and glutathione synthesis
in Plasmodium falciparum.
Muller S, Muller S
Redox Rep. 2003;8(5):251-5
37f. Plasmodium falciparum-infected red blood cells depend
on a functional glutathione de novo synthesis
attributable to an enhanced loss of glutathione.
Luersen K, Walter RD, Muller S, Lüersen K, Müller S
Biochem J. 2000 Mar 1;346 Pt 2:545-52
37g. Characterization of the glyoxalases of the malarial
parasite Plasmodium falciparum and comparison
with their human counterparts.
Akoachere M, Iozef R, Rahlfs S, Deponte M, Mannervik B,
Creighton DJ, Schirmer H, Becker K
Biol Chem. 2005 Jan;386(1):41-52
37h. Glutathione synthetase from Plasmodium falciparum.
Meierjohann S, Walter RD, Muller S
Biochem J. 2002 May 1;363(Pt 3):833-8
37i. Ceramide mediates growth inhibition of the Plasmodium
falciparum parasite.
Pankova-Kholmyansky I, Dagan A, Gold D, Zaslavsky Z,
Skutelsky E, Gatt S, Flescher E
Cell Mol Life Sci. 2003 Mar;60(3):577-87
37j. The malaria parasite supplies glutathione to its host
cell--investigation of glutathione transport and metabolism
in human erythrocytes infected with Plasmodium falciparum.
Atamna H, Ginsburg H
Eur J Biochem. 1997 Dec 15;250(3):670-9
37k. Redox processes in malaria and other parasitic diseases.
Determination of intracellular glutathione.
Becker K, Gui M, Traxler A, Kirsten C, Schirmer RH
Histochemistry. 1994 Nov;102(5):389-95
37L. The effect of Alcide, a new antimicrobial drug, on rat
blood glutathione and erythrocyte osmotic fragility, in vitro.
Abdel-Rahman MS, Scatina J
J Appl Toxicol. 1985 Jun;5(3):178-81
37m. Toxicity of chlorine dioxide in drinking water.
Abdel-Rahman MS, Couri D, Bull RJ
J Environ Pathol Toxicol Oncol. 1985 Sep-Oct;6(1):105-13
38a. Glutathione reductase-deficient erythrocytes
as host cells of malarial parasites.
Zhang Y, Konig I, Schirmer RH
Biochem Pharmacol. 1988 Mar 1;37(5):861-5
38b. Glutathione reductase of the malarial parasite
Plasmodium falciparum: crystal structure and inhibitor
development.
Sarma GN, Savvides SN, Becker K, Schirmer M, Schirmer RH,
Karplus PA
J Mol Biol. 2003 May 9;328(4):893-907
38c. Kinetic characterization of glutathione reductase
from the malarial parasite Plasmodium falciparum.
Comparison with the human enzyme.
Bohme CC, Arscott LD, Becker K, Schirmer RH, Williams CH Jr
J Biol Chem. 2000 Dec 1;275(48):37317-23
38d. Glutathione reductase inhibitors as potential
antimalarial drugs. Effects of nitrosoureas
on Plasmodium falciparum in vitro.
Zhang YA, Hempelmann E, Schirmer RH
Biochem Pharmacol. 1988 Mar 1;37(5):855-60
38e. Glutathione reductase inhibitors as potential
antimalarial drugs. Effects of nitrosoureas
on Plasmodium falciparum in vitro.
Zhang YA, Hempelmann E, Schirmer RH
Biochem Pharmacol. 1988 Mar 1;37(5):855-60
39a. Glutathione S-transferase of the malarial parasite
Plasmodium falciparum: characterization of a potential
drug target.
Harwaldt P, Rahlfs S, Becker K
Biol Chem. 2002 May;383(5):821-30
39b. Glutathione S-transferase from malarial parasites:
structural and functional aspects.
Deponte M, Becker K
Methods Enzymol. 2005;401:241-53
39c. The glutathione S-transferase from Plasmodium falciparum.
Liebau E, Bergmann B, Campbell AM, Teesdale-Spittle P,
Brophy PM, Lüersen K, Walter RD
Mol Biochem Parasitol. 2002 Sep-Oct;124(1-2):85-90
39d. Glutathione S-transferases and related proteins
from pathogenic human parasites behave
as immunomodulatory factors.
Ouaissi A, Ouaissi M, Sereno D
Immunol Lett. 2002 May 1;81(3):159-64
39e. Plasmodium falciparum glutathione S-transferase--
structural and mechanistic studies on ligand binding
and enzyme inhibition.
Hiller N, Fritz-Wolf K, Deponte M, Wende W,
Zimmermann H, Becker K
Protein Sci. 2006 Feb;15(2):281-9
39f. Cooperativity and pseudo-cooperativity in the
glutathione S-transferase from Plasmodium falciparum.
Liebau E, De Maria F, Burmeister C, Perbandt M,
Turella P, Antonini G, Federici G, Giansanti F,
Stella L, Lo Bello M, Caccuri AM, Ricci G
J Biol Chem. 2005 Jul 15;280(28):26121-8
39g. X-ray structure of glutathione S-transferase
from the malarial parasite Plasmodium falciparum.
Fritz-Wolf K, Becker A, Rahlfs S, Harwaldt P, Schirmer RH,
Kabsch W, Becker K
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13821-6
40a. Roles of 1-Cys peroxiredoxin in haem detoxification
in the human malaria parasite Plasmodium falciparum.
Kawazu S, Ikenoue N, Takemae H, Komaki-Yasuda K, Kano S
FEBS J. 2005 Apr;272(7):1784-91
40b. Structural and biochemical characterization
of a mitochondrial peroxiredoxin from Plasmodium
falciparum.
Boucher IW, McMillan PJ, Gabrielsen M, Akerman SE,
Brannigan JA, Schnick C, Brzozowski AM, Wilkinson AJ,
Muller S, Müller S
Mol Microbiol. 2006 Aug;61(4):948-59
40c. 2-Cys Peroxiredoxin TPx-1 is involved
in gametocyte development in Plasmodium berghei.
Yano K, Komaki-Yasuda K, Tsuboi T, Torii M, Kano S,
Kawazu S
Mol Biochem Parasitol. 2006 Jul;148(1):44-51
40d. Plasmodium falciparum 2-Cys peroxiredoxin reacts
with plasmoredoxin and peroxynitrite.
Nickel C, Trujillo M, Rahlfs S, Deponte M, Radi R,
Becker K
Biol Chem. 2005 Nov;386(11):1129-36
40e. Expression of mRNAs and proteins for peroxiredoxins
in Plasmodium falciparum erythrocytic stage.
Yano K, Komaki-Yasuda K, Kobayashi T, Takemae H,
Kita K, Kano S, Kawazu S
Parasitol Int. 2005 Mar;54(1):35-41
40f. Crystal structure of a novel Plasmodium falciparum
1-Cys peroxiredoxin.
Sarma GN, Nickel C, Rahlfs S, Fischer M, Becker K,
Karplus PA
J Mol Biol. 2005 Mar 4;346(4):1021-34
40g. 2-Cys peroxiredoxin PfTrx-Px1 is involved
in the antioxidant defence of Plasmodium falciparum.
Akerman SE, Muller S, Müller S
Mol Biochem Parasitol. 2003 Aug 31;130(2):75-81
40h. Expression profiles of peroxiredoxin proteins
of the rodent malaria parasite Plasmodium yoelii.
Kawazu S, Nozaki T, Tsuboi T, Nakano Y, Komaki-Yasuda K,
Ikenoue N, Torii M, Kano S
Int J Parasitol. 2003 Nov;33(13):1455-61
40i. Disruption of the Plasmodium falciparum 2-Cys
peroxiredoxin gene renders parasites hypersensitive
to reactive oxygen and nitrogen species.
Komaki-Yasuda K, Kawazu S, Kano S
FEBS Lett. 2003 Jul 17;547(1-3):140-4
40j. Molecular characterization of a 2-Cys peroxiredoxin
from the human malaria parasite Plasmodium falciparum.
Kawazu S, Komaki K, Tsuji N, Kawai S, Ikenoue N,
Hatabu T, Ishikawa H, Matsumoto Y, Himeno K, Kano S
Mol Biochem Parasitol. 2001 Aug;116(1):73-9
40k. Isolation and functional analysis of two thioredoxin
peroxidases (peroxiredoxins) from Plasmodium falciparum.
Krnajski Z, Walter RD, Muller S, Müller S
Mol Biochem Parasitol. 2001 Apr 6;113(2):303-8
40L. Thioredoxin peroxidases of the malarial parasite
Plasmodium falciparum.
Rahlfs S, Becker K
Eur J Biochem. 2001 Mar;268(5):1404-9
41a. The thioredoxin system of the malaria parasite
Plasmodium falciparum. Glutathione reduction revisited.
Kanzok SM, Schirmer RH, Turbachova I, Iozef R, Becker K
J Biol Chem. 2000 Dec 22;275(51):40180-6
41b. Thioredoxin networks in the malarial parasite
Plasmodium falciparum.
Nickel C, Rahlfs S, Deponte M, Koncarevic S, Becker K
Antioxid Redox Signal. 2006 Jul-Aug;8(7-8):1227-39
41c. Thioredoxin and glutathione system of malaria
parasite Plasmodium falciparum.
Muller S, Gilberger TW, Krnajski Z, Luersen K,
Meierjohann S, Walter RD, Muller S, Lüersen K
Protoplasma. 2001;217(1-3):43-9
41d. Thioredoxin reductase and glutathione synthesis
in Plasmodium falciparum.
Muller S, Muller S
Redox Rep. 2003;8(5):251-5
41e. Plasmodium falciparum thioredoxins and glutaredoxins
as central players in redox metabolism.
Rahlfs S, Nickel C, Deponte M, Schirmer RH, Becker K
Redox Rep. 2003;8(5):246-50
41f. The thioredoxin system of Plasmodium falciparum
and other parasites.
Rahlfs S, Schirmer RH, Becker K
Cell Mol Life Sci. 2002 Jun;59(6):1024-41
41g. Thioredoxin, thioredoxin reductase, and thioredoxin
peroxidase of malaria parasite Plasmodium falciparum.
Kanzok SM, Rahlfs S, Becker K, Schirmer RH
Methods Enzymol. 2002;347:370-81
42a. Plasmodium falciparum thioredoxins and glutaredoxins
as central players in redox metabolism.
Rahlfs S, Nickel C, Deponte M, Schirmer RH, Becker K
Redox Rep. 2003;8(5):246-50
42b. Plasmodium falciparum possesses a classical
glutaredoxin and a second, glutaredoxin-like protein
with a PICOT homology domain.
Rahlfs S, Fischer M, Becker K
J Biol Chem. 2001 Oct 5;276(40):37133-40
42c. Plasmodium falciparum glutaredoxin-like proteins.
Deponte M, Becker K, Rahlfs S
Biol Chem. 2005 Jan;386(1):33-40
43a. Plasmoredoxin, a novel redox-active protein
unique for malarial parasites.
Becker K, Kanzok SM, Iozef R, Fischer M, Schirmer RH,
Rahlfs S
Eur J Biochem. 2003 Mar;270(6):1057-64
44a. Double-drug development against antioxidant enzymes
from Plasmodium falciparum.
Biot C, Dessolin J, Grellier P, Davioud-Charvet E
Redox Rep. 2003;8(5):280-3
44b. Thioredoxin reductase and glutathione synthesis
in Plasmodium falciparum.
Muller S, Muller S
Redox Rep. 2003;8(5):251-5
44c. Specific inhibitors of Plasmodium falciparum
thioredoxin reductase as potential antimalarial agents.
Andricopulo AD, Akoachere MB, Krogh R, Nickel C,
McLeish MJ, Kenyon GL, Arscott LD, Williams CH Jr,
Davioud-Charvet E, Becker K
Bioorg Med Chem Lett. 2006 Apr 15;16(8):2283-92
44d. Thioredoxin, thioredoxin reductase, and thioredoxin
peroxidase of malaria parasite Plasmodium falciparum.
Kanzok SM, Rahlfs S, Becker K, Schirmer RH
Methods Enzymol. 2002;347:370-81
44e. Thioredoxin reductase is essential for the survival
of Plasmodium falciparum erythrocytic stages.
Krnajski Z, Gilberger TW, Walter RD, Cowman AF, Muller S
J Biol Chem. 2002 Jul 19;277(29):25970-5;Epub 2002 May 09
44f. Thioredoxin reductase as a pathophysiological
factor and drug target.
Becker K, Gromer S, Schirmer RH, Muller S
Eur J Biochem. 2000 Oct;267(20):6118-25
44g. Redox and antioxidant systems of the malaria parasite
Plasmodium falciparum.
Muller S
Mol Microbiol. 2004 Sep;53(5):1291-305
45a. Gene disruption confirms a critical role for the
cysteine protease falcipain-2 in hemoglobin hydrolysis
by Plasmodium falciparum.
Sijwali PS, Rosenthal PJ
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4384-9
45b. Plasmodium falciparum cysteine protease falcipain-2
cleaves erythrocyte membrane skeletal proteins at late
stages of parasite development.
Hanspal M, Dua M, Takakuwa Y, Chishti AH, Mizuno A
Blood. 2002 Aug 1;100(3):1048-54
45c. Expression and characterization of the Plasmodium
falciparum haemoglobinase falcipain-3.
Sijwali PS, Shenai BR, Gut J, Singh A, Rosenthal PJ
Biochem J. 2001 Dec 1;360(Pt 2):481-9
45d. Characterization of native and recombinant falcipain-2,
a principal trophozoite cysteine protease and essential
hemoglobinase of Plasmodium falciparum.
Shenai BR, Sijwali PS, Singh A, Rosenthal PJ
J Biol Chem. 2000 Sep 15;275(37):29000-10
45e. Reducing requirements for hemoglobin hydrolysis
by Plasmodium falciparum cysteine proteases.
Shenai BR, Rosenthal PJ
Mol Biochem Parasitol. 2002 Jun;122(1):99-104
45f. Cysteine proteases of malaria parasites.
Rosenthal PJ
Int J Parasitol. 2004 Dec;34(13-14):1489-99
45g. Responsiveness of parasite Cys His proteases
to iron redox.
Lockwood TD
Parasitol Res. 2006 Dec;100(1):175-81
45h. Antimalarial activities of novel synthetic cysteine
protease inhibitors.
Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA,
Weinhouse MI, Vlasuk GP, Rosenthal PJ
Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4
45i. Responsiveness of parasite Cys His proteases to iron redox.
Lockwood TD
Parasitol Res. 2006 Dec;100(1):175-81
46a. Comparative properties of a three-dimensional model
of Plasmodium falciparum ornithine decarboxylase.
Birkholtz L, Joubert F, Neitz AW, Louw AI
Proteins. 2003 Feb 15;50(3):464-73
46b. The Plasmodium falciparum bifunctional ornithine
decarboxylase, S-adenosyl-L-methionine decarboxylase,
enables a well balanced polyamine synthesis without
domain-domain interaction.
Wrenger C, Luersen K, Krause T, Muller S, Walter RD
J Biol Chem. 2001 Aug 10;276(32):29651-6
46c. The ornithine decarboxylase domain of the
bifunctional ornithine decarboxylase/S-adenosylmethionine
decarboxylase of Plasmodium falciparum:
recombinant expression and catalytic properties
of two different constructs.
Krause T, Lüersen K, Wrenger C, Gilberger TW, Müller S,
Walter RD
Biochem J. 2000 Dec 1;352 Pt 2:287-92
46d. In the human malaria parasite Plasmodium falciparum,
polyamines are synthesized by a bifunctional ornithine
decarboxylase, S-adenosylmethionine decarboxylase.
Müller S, Da'dara A, Lüersen K, Wrenger C, Das Gupta R,
Madhubala R, Walter RD
J Biol Chem. 2000 Mar 17;275(11):8097-102
46e. Ornithine decarboxylase of Plasmodium falciparum:
a peak-function enzyme and its inhibition by chloroquine.
Königk E, Putfarken B
Trop Med Parasitol. 1985 Jun;36(2):81-4
47a. Plasmodium falciparum: inhibitors of lysosomal
cysteine proteinases inhibit a trophozoite proteinase
and block parasite development.
Rosenthal PJ, McKerrow JH, Rasnick D, Leech JH
Mol Biochem Parasitol. 1989 Jun 15;35(2):177-83
47b. Intraerythrocytic Plasmodium falciparum utilizes only
a fraction of the amino acids derived from the digestion
of host cell cytosol for the biosynthesis of its proteins.
Krugliak M, Zhang J, Ginsburg H
Mol Biochem Parasitol. 2002 Feb;119(2):249-56
47c. Hemoglobin degradation.
Goldberg DE
Curr Top Microbiol Immunol. 2005;295:275-91
47d. Hemoglobin metabolism in the malaria parasite
Plasmodium falciparum.
Francis SE, Sullivan DJ Jr, Goldberg DE
Annu Rev Microbiol. 1997;51:97-123
47e. Acidification of the malaria parasite's digestive
vacuole by a H+-ATPase and a H+-pyrophosphatase.
Saliba KJ, Allen RJ, Zissis S, Bray PG, Ward SA, Kirk K
J Biol Chem. 2003 Feb 21;278(8):5605-12
47f. Hemoglobin degradation in Plasmodium-infected
red blood cells.
Goldberg DE
Semin Cell Biol. 1993 Oct;4(5):355-61
47g. Plasmodial hemoglobin degradation:
an ordered pathway in a specialized organelle.
Goldberg DE
Infect Agents Dis. 1992 Aug;1(4):207-11
47h. pH regulation in the intracellular malaria parasite,
Plasmodium falciparum. H(+) extrusion via a v-type h(+)-atpase.
Saliba KJ, Kirk K
J Biol Chem. 1999 Nov 19;274(47):33213-9
48a. Plasmodium falciparum carbohydrate metabolism:
a connection between host cell and parasite.
Roth E Jr
Blood Cells. 1990;16(2-3):453-60; discussion 461-6
48b. The effect of Alcide, a new antimicrobial drug, on rat
blood glutathione and erythrocyte osmotic fragility, in vitro.
Abdel-Rahman MS, Scatina J
J Appl Toxicol. 1985 Jun;5(3):178-81
49a. Development of cysteine protease inhibitors as
chemotherapy for parasitic diseases: insights on
safety, target validation, and mechanism of action.
McKerrow JH
Int J Parasitol. 1999 Jun;29(6):833-7
49b. Cysteine proteases of malaria parasites:
targets for chemotherapy.
Rosenthal PJ, Sijwali PS, Singh A, Shenai BR
Curr Pharm Des. 2002;8(18):1659-72
49c. Proteases of malaria parasites:
new targets for chemotherapy.
Rosenthal PJ
Emerg Infect Dis. 1998 Jan-Mar;4(1):49-57
49d. Hydrolysis of erythrocyte proteins
by proteases of malaria parasites.
Rosenthal PJ
Curr Opin Hematol. 2002 Mar;9(2):140-5
49e. Cysteine protease inhibitors as chemotherapy
for parasitic infections.
McKerrow JH, Engel JC, Caffrey CR
Bioorg Med Chem. 1999 Apr;7(4):639-44
50a. In vitro activity of riboflavin against the human
malaria parasite Plasmodium falciparum.
Akompong T, Ghori N, Haldar K
Antimicrob Agents Chemother. 2000 Ja ;44(1):88-96
50b. Potentiation of an antimalarial oxidant drug.
Winter RW, Ignatushchenko M, Ogundahunsi OA, Cornell KA,
Oduola AM, Hinrichs DJ, Riscoe MK
Antimicrob Agents Chemother. 1997 Jul;41(7):1449-54
50c. Hemoglobin metabolism in the malaria parasite
Plasmodium falciparum.
Francis SE, Sullivan DJ Jr, Goldberg DE
Annu Rev Microbiol. 1997;51:97-123
50d. Identification and characterization of heme-interacting
proteins in the malaria parasite, Plasmodium falciparum.
Campanale N, Nickel C, Daubenberger CA, Wehlan DA,
Gorman JJ, Klonis N, Becker K, Tilley L
J Biol Chem. 2003 Jul 25;278(30):27354-61
50e. The redox status of malaria-infected erythrocytes:
an overview with an emphasis on unresolved problems.
Ginsburg H, Atamna H
Parasite. 1994 Mar;1(1):5-13
50f. Redox and antioxidant systems of the malaria parasite
Plasmodium falciparum.
Muller S
Mol Microbiol. 2004 Sep;53(5):1291-305
50g. Origin of reactive oxygen species in erythrocytes
infected with Plasmodium falciparum.
Atamna H, Ginsburg H
Mol Biochem Parasitol. 1993 Oct;61(2):231-41
Erratum in: Mol Biochem Parasitol 1994 Feb;63(2):312
50h. Oxidative stress in malaria parasite-infected
erythrocytes: host-parasite interactions.
Becker K, Tilley L, Vennerstrom JL, Roberts D,
Rogerson S, Ginsburg H
Int J Parasitol. 2004 Feb;34(2):163-89
50i. Clotrimazole binds to heme and enhances heme-dependent
hemolysis: proposed antimalarial mechanism of clotrimazole.
Huy NT, Kamei K, Yamamoto T, Kondo Y, Kanaori K,
Takano R, Tajima K, Hara S
J Biol Chem. 2002 Feb 8;277(6):4152-8
50j. Illumination of the malaria parasite Plasmodium
falciparum alters intracellular pH. Implications
for live cell imaging.
Wissing F, Sanchez CP, Rohrbach P, Ricken S, Lanzer M
J Biol Chem. 2002 Oct 4;277(40):37747-55
50k. Potentiation of an antimalarial oxidant drug.
Winter RW, Ignatushchenko M, Ogundahunsi OA, Cornell KA,
Oduola AM, Hinrichs DJ, Riscoe MK
Antimicrob Agents Chemother. 1997 Jul;41(7):1449-54
50L. The iron environment in heme and heme-antimalarial
complexes of pharmacological interest.
Adams PA, Berman PA, Egan TJ, Marsh PJ, Silver J
J Inorg Biochem. 1996 Jul;63(1):69-77
50m. Lysis of malarial parasites and erythrocytes
by ferriprotoporphyrin IX-chloroquine and the inhibition
of this effect by proteins.
Zhang Y, Hempelmann E
Biochem Pharmacol. 1987 Apr 15;36(8):1267-73
50n. Ferriprotoporphyrin IX: a mediator of the antimalarial
action of oxidants and 4-aminoquinoline drugs.
Fitch CD, Dutta P, Kanjananggulpan P, Chevli R
Prog Clin Biol Res. 1984;155:119-30
50o. Hemolysis of mouse erythrocytes by ferriprotoporphyrin IX
and chloroquine. Chemotherapeutic implications.
Chou AC, Fitch CD
J Clin Invest. 1980 Oct;66(4):856-8
50p. Is hemin responsible for the susceptibility
of Plasmodia to oxidant stress?
Har-El R, Marva E, Chevion M, Golenser J
Free Radic Res Commun. 1993;18(5):279-90
50q. The effects of ascorbate-induced free radicals
on Plasmodium falciparum.
Marva E, Golenser J, Cohen A, Kitrossky N, Har-el R,
Chevion M
Trop Med Parasitol. 1992 Mar;43(1):17-23
50r. Induction of oxidant stress by iron available
in advanced forms of Plasmodium falciparum.
Golenser J, Marva E, Har-El R, Chevion M
Free Radic Res Commun. 1991;12-13 Pt 2:639-43
50s. Growth inhibition of Plasmodium falciparum involving
carbon centered iron-chelate radical (L., X-)-Fe(III)
based on pyridoxal-betaine. A novel type of antimalarials
active against chloroquine-resistant parasites.
Iheanacho EN, Sarel S, Samuni A, Avramovici-Grisaru S,
Spira DT
Free Radic Res Commun. 1991;15(1):1-10
50t. Detection of short-chain carbonyl products of lipid
peroxidation from malaria-parasite (Plasmodium vinckei)-
infected red blood cells exposed to oxidative stress.
Buffinton GD, Hunt NH, Cowden WB, Clark IA
Biochem J. 1988 Jan 1;249(1):63-8
50u. Ferriprotoporphyrin IX: a mediator of the antimalarial
action of oxidants and 4-aminoquinoline drugs.
Fitch CD, Dutta P, Kanjananggulpan P, Chevli R
Prog Clin Biol Res. 1984;155:119-30
50v. Influence of chloroquine treatment and Plasmodium
falciparum malaria infection on some enzymatic and
non-enzymatic antioxidant defense indices in humans.
Farombi EO, Shyntum YY, Emerole GO
Drug Chem Toxicol. 2003 Feb;26(1):59-71
50w. Oxidative stress in patients with non-complicated malaria.
Pabón A, Carmona J, Burgos LC, Blair S
Clin Biochem. 2003 Feb;36(1):71-8
50x. Evidence for erythrocyte lipid peroxidation
in acute falciparum malaria.
Das BS, Nanda NK
Trans R Soc Trop Med Hyg. 1999 Jan-Feb;93(1):58-62
50y. Metal chelators/antioxidants: approaches to protect
erythrocytic oxidative stress injury during Plasmodium
berghei infection in Mastomys coucha.
Srivastava PJ, Chandra S, Arif AJ, Singh C, Panday V
Pharmacol Res. 1999 Sep;40(3):239-41
50z. Role of free radicals in Plasmodium berghei infected
Mastomys natalensis brain.
Mahdi AA, Chander R, Kapoor NK, Ahmad S
Indian J Exp Biol. 1992 Dec;30(12):1193-6
50aa. Plasmodium falciparum induced perturbations
of the erythrocyte antioxidant system.
Mohan K, Dubey ML, Ganguly NK, Mahajan RC
Clin Chim Acta. 1992 Jul 31;209(1-2):19-26
50bb. Effect of radical treatment on erythrocyte lipid
peroxidation in Plasmodium vivax-infected malaria patients.
Mathews ST, Selvam R
Biochem Int. 1991 Sep;25(2):211-20
51a. The survival of Plasmodium Under oxidant stress.
Golenser J, Marva E, Chevion M
Parasitol Today. 1991 Jun;7(6):142-6
51b. Hexose-monophosphate shunt activity in intact
Plasmodium falciparum-infected erythrocytes and
in free parasites.
Atamna H, Pascarmona G, Ginsburg H
Mol Biochem Parasitol. 1994 Sep;67(1):79-89
51c. Vampires, Pasteur and reactive oxygen species.
Is the switch from aerobic to anaerobic metabolism
a preventive antioxidant defence in blood-feeding
parasites?
Oliveira PL, Oliveira MF
FEBS Lett. 2002 Aug 14;525(1-3):3-6
51d. Oxidative stress and malaria-infected erythrocytes.
Mishra NC, Kabilan L, Sharma A
Indian J Malariol. 1994 Jun;31(2):77-87
51e. Oxidative stress and antioxidant defence mechanism
in Plasmodium vivax malaria before and after chloroquine
treatment.
Sarin K, Kumar A, Prakash A, Sharma A
Indian J Malariol. 1993 Sep;30(3):127-33
51f. Lipid peroxidation in Plasmodium falciparum-
parasitized human erythrocytes.
Simões AP, van den Berg JJ, Roelofsen B, Op den Kamp JA
Arch Biochem Biophys. 1992 Nov 1;298(2):651-7
51g. The adaptation of Plasmodium falciparum to oxidative
stress in G6PD deficient human erythrocytes.
Roth E Jr, Schulman S
Br J Haematol. 1988 Nov;70(3):363-7
51h. Pathways for the reduction of oxidized glutathione
in the Plasmodium falciparum-infected erythrocyte:
can parasite enzymes replace host red cell
glucose-6-phosphate dehydrogenase?
Roth EF Jr, Schulman S, Vanderberg J, Olson J
Blood. 1986 Mar;67(3):827-30
51i. The plasmodial apicoplast was retained under
evolutionary selective pressure to assuage blood stage
oxidative stress.
Toler S
Med Hypotheses. 2005;65(4):683-90
51j. Glutathione--functions and metabolism in the malarial
parasite Plasmodium falciparum.
Becker K, Rahlfs S, Nickel C, Schirmer RH
Biol Chem. 2003 Apr;384(4):551-66
51k. Oxidative stress and antioxidant defenses:
a target for the treatment of diseases caused
by parasitic protozoa.
Turrens JF
Mol Aspects Med. 2004 Feb-Apr;25(1-2):211-20
51L. Vampires, Pasteur and reactive oxygen species.
Is the switch from aerobic to anaerobic metabolism
a preventive antioxidant defence in blood-feeding
parasites?
Oliveira PL, Oliveira MF
FEBS Lett. 2002 Aug 14;525(1-3):3-6
51m. The malaria parasite supplies glutathione to its host
cell--investigation of glutathione transport and metabolism
in human erythrocytes infected with Plasmodium falciparum.
Atamna H, Ginsburg H
Eur J Biochem. 1997 Dec 15;250(3):670-9
51n. Redox processes in malaria and other parasitic diseases.
Determination of intracellular glutathione.
Becker K, Gui M, Traxler A, Kirsten C, Schirmer RH
Histochemistry. 1994 Nov;102(5):389-95
52a. Effect of antifungal azoles on the heme detoxification
system of malarial parasite.
Huy NT, Kamei K, Kondo Y, Serada S, Kanaori K, Takano R,
Tajima K, Hara S
J Biochem (Tokyo). 2002 Mar;131(3):437-44
52b. Malarial haemozoin/beta-haematin supports haem
polymerization in the absence of protein.
Dorn A, Stoffel R, Matile H, Bubendorf A, Ridley RG
Nature. 1995 Mar 16;374(6519):269-71
52c. Plasmodium falciparum histidine-rich protein-2
(PfHRP2) modulates the redox activity
of ferri-protoporphyrin IX (FePPIX): peroxidase-like
activity of the PfHRP2-FePPIX complex.
Mashima R, Tilley L, Siomos MA, Papalexis V,
Raftery MJ, Stocker R
J Biol Chem. 2002 Apr 26;277(17):14514-20
52d. Hemoglobin degradation in malaria-infected erythrocytes
determined from live cell magnetophoresis.
Moore LR, Fujioka H, Williams PS, Chalmers JJ, Grimberg B,
Zimmerman PA, Zborowski M
FASEB J. 2006 Apr;20(6):747-9
52e. A physiochemical mechanism of hemozoin (beta-hematin)
synthesis by malaria parasite.
Tripathi AK, Garg SK, Tekwani BL
Biochem Biophys Res Commun. 2002 Jan 11;290(1):595-601
52f. Histidine-rich protein 2 of the malaria parasite,
Plasmodium falciparum, is involved in detoxification
of the by-products of haemoglobin degradation.
Papalexis V, Siomos MA, Campanale N, Guo X, Kocak G,
Foley M, Tilley L
Mol Biochem Parasitol. 2001 Jun;115(1):77-86
52g. Theories on malarial pigment formation and quinoline
action.
Sullivan DJ
Int J Parasitol. 2002 Dec 4;32(13):1645-53
52h. A comparison and analysis of several ways to promote
haematin (haem) polymerisation and an assessment
of its initiation in vitro.
Dorn A, Vippagunta SR, Matile H, Bubendorf A,
Vennerstrom JL, Ridley RG
Biochem Pharmacol. 1998 Mar 15;55(6):737-47
52i. Plasmodium hemozoin formation mediated
by histidine-rich proteins.
Sullivan DJ Jr, Gluzman IY, Goldberg DE
Science. 1996 Jan 12;271(5246):219-22
52j. An iron-carboxylate bond links the heme units
of malaria pigment.
Slater AF, Swiggard WJ, Orton BR, Flitter WD, Goldberg DE,
Cerami A, Henderson GB
Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):325-9
52k. Hemozoin induces macrophage chemokine expression through
oxidative stress-dependent and -independent mechanisms.
Jaramillo M, Godbout M, Olivier M
J Immunol. 2005 Jan 1;174(1):475-84
53a. A non-radiolabeled heme-GSH interaction test
for the screening of antimalarial compounds.
Garavito G, Monje MC, Maurel S, Valentin A, Nepveu F,
Deharo E
Exp Parasitol. 2007 Jan 23
53b. Effect of antifungal azoles on the heme detoxification
system of malarial parasite.
Huy NT, Kamei K, Kondo Y, Serada S, Kanaori K, Takano R,
Tajima K, Hara S
J Biochem (Tokyo). 2002 Mar;131(3):437-44
54a. A comparison of the effects of ocular preservatives
on mammalian and microbial ATP and glutathione levels.
Ingram PR, Pitt AR, Wilson CG, Olejnik O, Spickett CM
Free Radic Res. 2004 Jul;38(7):739-50
54b. The effect of Alcide, a new antimicrobial drug,
on rat blood glutathione and erythrocyte osmotic
fragility, in vitro.
Abdel-Rahman MS, Scatina J
J Appl Toxicol. 1985 Jun;5(3):178-81
55a. Inhibition of the peroxidative degradation of haem as
the basis of action of chloroquine and other quinoline
antimalarials.
Loria P, Miller S, Foley M, Tilley L
Biochem J. 1999 Apr 15;339 ( Pt 2):363-70
55b. Quinoline antimalarials: mechanisms of action and
resistance and prospects for new agents.
Foley M, Tilley L
Pharmacol Ther. 1998 Jul;79(1):55-87
55c. Quinoline antimalarials:
mechanisms of action and resistance.
Foley M, illey L
Int J Parasitol. 1997 Feb;27(2):231-40
55d. Inhibition by anti-malarial drugs of haemoglobin
denaturation and iron release in acidified red blood cell
lysates--a possible mechanism of their anti-malarial effect?
Gabay T, Krugliak M, Shalmiev G, Ginsburg H
Parasitology. 1994 May;108 ( Pt 4):371-81
55e. Chloroquine: mechanism of drug action and resistance
in Plasmodium falciparum.
Slater AF
Pharmacol Ther. 1993 Feb-Mar;57(2-3):203-35
55f. The treatment of Plasmodium falciparum-infected
erythrocytes with chloroquine leads to accumulation
of ferriprotoporphyrin IX bound to particular parasite
proteins and to the inhibition of the parasite's
6-phosphogluconate dehydrogenase.
Famin O, Ginsburg H
Parasite. 2003 Mar;10(1):39-50
55g. Chloroquine - some open questions on its antimalarial
mode of action and resistance.
Ginsburg H, Krugliak M
Drug Resist Updat. 1999 Jun;2(3):180-187
55h. Kinetics of inhibition of glutathione-mediated degradation
of ferriprotoporphyrin IX by antimalarial drugs.
Famin O, Krugliak M, Ginsburg H
Biochem Pharmacol. 1999 Jul 1;58(1):59-68
55i. The fate of ferriprotorphyrin IX in malaria infected
erythrocytes in conjunction with the mode of action
of antimalarial drugs.
Zhang J, Krugliak M, Ginsburg H
Mol Biochem Parasitol. 1999 Mar 15;99(1):129-41
55j. Inhibition of glutathione-dependent degradation
of heme by chloroquine and amodiaquine as a possible basis
for their antimalarial mode of action.
Ginsburg H, Famin O, Zhang J, Krugliak M
Biochem Pharmacol. 1998 Nov 15;56(10):1305-13
55k. Antimalarial drugs inhibiting hemozoin (beta-hematin)
formation: a mechanistic update.
Kumar S, Guha M, Choubey V, Maity P, Bandyopadhyay U
Life Sci. 2007 Feb 6;80(9):813-28
55L. A medicinal chemistry perspective on 4-aminoquinoline
antimalarial drugs.
O'Neill PM, Ward SA, Berry NG, Jeyadevan JP, Biagini GA,
Asadollaly E, Park BK, Bray PG
Curr Top Med Chem. 2006;6(5):479-507
55m. Heme Aggregation inhibitors: antimalarial drugs
targeting an essential biomineralization process.
Ziegler J, Linck R, Wright DW
Curr Med Chem. 2001 Feb;8(2):171-89
55n. Structural specificity of chloroquine-hematin
binding related to inhibition of hematin polymerization
and parasite growth.
Vippagunta SR, Dorn A, Matile H, Bhattacharjee AK,
Karle JM, Ellis WY, Ridley RG, Vennerstrom JL
J Med Chem. 1999 Nov 4;42(22):4630-9
55o. A common mechanism for blockade of heme
polymerization by antimalarial quinolines.
Sullivan DJ Jr, Matile H, Ridley RG, Goldberg DE
J Biol Chem. 1998 Nov 20;273(47):31103-7
55p. Central role of hemoglobin degradation in mechanisms
of action of 4-aminoquinolines, quinoline methanols,
and phenanthrene methanols.
Mungthin M, Bray PG, Ridley RG, Ward SA
Antimicrob Agents Chemother. 1998 Nov;42(11):2973-7
55q. Access to hematin: the basis of chloroquine resistance.
Bray PG, Mungthin M, Ridley RG, Ward SA
Mol Pharmacol. 1998 Jul;54(1):170-9
55r. Involvement of heme in the antimalarial action of chloroquine.
Fitch CD
Trans Am Clin Climatol Assoc. 1998;109:97-105; discussion 105-6
55s. Relationship between antimalarial drug activity,
accumulation, and inhibition of heme polymerization
in Plasmodium falciparum in vitro.
Hawley SR, Bray PG, Mungthin M, Atkinson JD, O'Neill PM,
Ward SA
Antimicrob Agents Chemother. 1998 Mar;42(3):682-6
55t. Haematin (haem) polymerization and its inhibition
by quinoline antimalarials.
Ridley RG, Dorn A, Vippagunta SR, Vennerstrom JL
Ann Trop Med Parasitol. 1997 Jul;91(5):559-66
55u. Heme polymerase activity and the stage specificity
of antimalarial action of chloroquine.
Orjih AU
J Pharmacol Exp Ther. 1997 Jul;282(1):108-12
55v. Xanthones as antimalarial agents;
studies of a possible mode of action.
Ignatushchenko MV, Winter RW, Bächinger HP, Hinrichs DJ,
Riscoe MK
FEBS Lett. 1997 Jun 2;409(1):67-73
55w. Depolymerization of malarial hemozoin: a novel reaction
initiated by blood schizontocidal antimalarials.
Pandey AV, Tekwani BL
FEBS Lett. 1997 Feb 3;402(2-3):236-40
55x. On the molecular mechanism of chloroquine's
antimalarial action.
Sullivan DJ Jr, Gluzman IY, Russell DG, Goldberg DE
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11865-70
55y. Hemoglobin catabolism and the killing of intraerythrocytic
Plasmodium falciparum by chloroquine.
Orjih AU, Ryerse JS, Fitch CD
Experientia. 1994 Jan 15;50(1):34-9
55z. Antimalarial 4-aminoquinolines: mode of action
and pharmacokinetics.
Pussard E, Verdier F
Fundam Clin Pharmacol. 1994;8(1):1-17
55aa. Hemoglobin catabolism and host-parasite heme balance
in chloroquine-sensitive and chloroquine-resistant
Plasmodium berghei infections.
Wood PA, Eaton JW
Am J Trop Med Hyg. 1993 Apr;48(4):465-72
55bb. Quinoline-containing antimalarials--
mode of action, drug resistance and its reversal.
An update with unresolved puzzles.
Ginsburg H, Krugliak M
Biochem Pharmacol. 1992 Jan 9;43(1):63-70
55cc. Inhibition by chloroquine of a novel haem
polymerase enzyme activity in malaria trophozoites.
Slater AF, Cerami A
Nature. 1992 Jan 9;355(6356):167-9
Comment in: Nature. 1992 Jan 9;355(6356):108-9
55dd. Heme polymerase: modulation by chloroquine treatment
of a rodent malaria.
Chou AC, Fitch CD
Life Sci. 1992;51(26):2073-8
55ee. Mode of action of antimalarial drugs.
Fitch CD
Ciba Found Symp. 1983;94:222-32
55ff. Binding of antimalarial drugs to hemozoin
from Plasmodium berghei.
Jearnpipatkul A, Govitrapong P, Yuthavong Y, Wilairat P,
Panijpan B
Experientia. 1980 Sep 15;36(9):1063-4
55gg. Influence of chloroquine treatment and Plasmodium
falciparum malaria infection on some enzymatic and
non-enzymatic antioxidant defense indices in humans.
Farombi EO, Shyntum YY, Emerole GO
Drug Chem Toxicol. 2003 Feb;26(1):59-71
56a. Regulation of intracellular glutathione levels
in erythrocytes infected with chloroquine-sensitive
and chloroquine-resistant Plasmodium falciparum.
Meierjohann S, Walter RD, Muller S, Müller S
Biochem J. 2002 Dec 15;368(Pt 3):761-8
56b. The malaria parasite supplies glutathione to its
host cell--investigation of glutathione transport and
metabolism in human erythrocytes infected with
Plasmodium falciparum.
Atamna H, Ginsburg H
Eur J Biochem. 1997 Dec 15;250(3):670-9
56c. Is the expression of genes encoding enzymes of
glutathione (GSH) metabolism involved in chloroquine
resistance in Plasmodium chabaudi parasites?
Ferreira ID, Nogueira F, Borges ST, do Rosario VE,
Cravo P, do Rosyo VE
Mol Biochem Parasitol. 2004 Jul;136(1):43-50
56d. Plasmodium falciparum glutathione metabolism and growth
are independent of glutathione system of host erythrocyte.
Ayi K, Cappadoro M, Branca M, Turrini F, Arese P
FEBS Lett. 1998 Mar 13;424(3):257-61
56e. Glutathione-S-transferases from chloroquine-resistant
and -sensitive strains of Plasmodium falciparum:
what are their differences?
Rojpibulstit P, Kangsadalampai S, Ratanavalachai T,
Denduangboripant J, Chavalitshewinkoon-Petmitr P
Southeast Asian J Trop Med Public Health. 2004 Jun;35(2):292-9
56f. Plasmodium berghei: analysis of the gamma-glutamylcysteine
synthetase gene in drug-resistant lines.
Perez-Rosado J, Gervais GW, Ferrer-Rodriguez I, Peters W,
Serrano AE, Pérez-Rosado J, Ferrer-RodrÃguez I
Exp Parasitol. 2002 Aug;101(4):175-82
56g. Glutathione-S-transferase activity in malarial parasites.
Srivastava P, Puri SK, Kamboj KK, Pandey VC
Trop Med Int Health. 1999 Apr;4(4):251-4
56h. Role of glutathione in the detoxification of
ferriprotoporphyrin IX in chloroquine resistant
Plasmodium berghei.
Platel DF, Mangou F, Tribouley-Duret J
Mol Biochem Parasitol. 1999 Jan 25;98(2):215-23
56i. Plasmodium berghei: implication of intracellular
glutathione and its related enzyme in chloroquine
resistance in vivo.
Dubois VL, Platel DF, Pauly G, Tribouley-Duret J
Exp Parasitol. 1995 Aug;81(1):117-24
56j. Amodiaquine failure associated with erythrocytic
glutathione in Plasmodium falciparum malaria.
Zuluaga L, Pabon A, Lopez C, Ochoa A, Blair S
Malar J. 2007 Apr 23;6(1):47
57a. A prodrug form of a Plasmodium falciparum glutathione
reductase inhibitor conjugated with a 4-anilinoquinoline.
Davioud-Charvet E, Delarue S, Biot C, Schwobel B, Boehme CC,
Mussigbrodt A, Maes L, Sergheraert C, Grellier P,
Schirmer RH, Becker K, Schwöbel B, Müssigbrodt A
J Med Chem. 2001 Nov 22;44(24):4268-76
57b. Deletion of the parasite-specific insertions and
mutation of the catalytic triad in glutathione
reductase from chloroquine-sensitive Plasmodium
falciparum 3D7.
Gilberger TW, Schirmer RH, Walter RD, Müller S
Mol Biochem Parasitol. 2000 Apr 15;107(2):169-79
57c. Potentiation of the antimalarial action of chloroquine
in rodent malaria by drugs known to reduce cellular
glutathione levels.
Deharo E, Barkan D, Krugliak M, Golenser J, Ginsburg H
Biochem Pharmacol. 2003 Sep 1;66(5):809-17
57d. Glutathione is involved in the antimalarial action
of chloroquine and its modulation affects drug
sensitivity of human and murine species of Plasmodium.
Ginsburg H, Golenser J
Redox Rep. 2003;8(5):276-9
57e. Double-drug development against antioxidant enzymes
from Plasmodium falciparum.
Biot C, Dessolin J, Grellier P, Davioud-Charvet E
Redox Rep. 2003;8(5):280-3
57f. Plasmodium falciparum: in vitro interactions
of artemisinin with amodiaquine, pyronaridine,
and chloroquine
Gupta S, Thapar MM, Mariga ST, Wernsdorfer WH, Bjorkman A
Exp Parasitol. 2002 Jan;100(1):28-35
57g. Potentiation of chloroquine activity against Plasmodium
falciparum by the peroxidase-hydrogen peroxide system.
Malhotra K, Salmon D, Le Bras J, Vilde JL
Antimicrob Agents Chemother. 1990 Oct;34(10):1981-5
58a. Oxidation of pharmaceuticals during water treatment
with chlorine dioxide.
Huber MM, Korhonen S, Ternes TA, von Gunten U
Water Res. 2005 Sep;39(15):3607-17
59a. Malarial parasite hexokinase and hexokinase-dependent
glutathione reduction in the Plasmodium falciparum
infected human erythrocyte.
Roth EF Jr
J Biol Chem. 1987 Nov 15;262(32):15678-82
59b. Double-drug development against antioxidant enzymes
from Plasmodium falciparum.
Biot C, Dessolin J, Grellier P, Davioud-Charvet E
Redox Rep. 2003;8(5):280-3
59c. Plasmodium falciparum carbohydrate metabolism:
a connection between host cell and parasite.
Roth E Jr.
Blood Cells. 1990;16(2-3):453-60; discussion 461-6
59d. Hexose-monophosphate shunt activity in intact
Plasmodium falciparum-infected erythrocytes and
in free parasites.
Atamna H, Pascarmona G, Ginsburg H
Mol Biochem Parasitol. 1994 Sep;67(1):79-89
60a. Redox metabolism in glucose-6-phosphate dehydrogenase
deficient erythrocytes and its relation to antimalarial
chemotherapy.
Ginsburg H, Golenser J
Parassitologia. 1999 Sep;41(1-3):309-11
60b. Plasmodium falciparum: thiol status and growth
in normal and glucose-6-phosphate dehydrogenase
deficient human erythrocytes.
Miller J, Golenser J, Spira DT, Kosower NS
Exp Parasitol. 1984 Jun;57(3):239-47
60c. Plasmodium berghei: dehydroepiandrosterone sulfate
reverses chloroquino-resistance in experimental malaria
infection; correlation with glucose 6-phosphate
dehydrogenase and glutathione synthesis pathway.
Safeukui I, Mangou F, Malvy D, Vincendeau P,
Mossalayi D, Haumont G, Vatan R, Olliaro P, Millet P
Biochem Pharmacol. 2004 Nov 15;68(10):1903-10
60d. Resistance of glucose-6-phosphate dehydrogenase
deficiency to malaria: effects of fava bean hydroxypyrimidine
glucosides on Plasmodium falciparum growth in culture and
on the phagocytosis of infected cells.
Ginsburg H, Atamna H, Shalmiev G, Kanaani J, Krugliak M
Parasitology. 1996 Jul;113 ( Pt 1):7-18
60e. Inhibition of the intraerythrocytic development
of Plasmodium falciparum in glucose-6-phosphate
dehydrogenase deficient erythrocytes is enhanced
by oxidants and by crisis form factor.
Golenser J, Miller J, Spira DT, Kosower NS,
Vande Waa JA, Jensen JB
Trop Med Parasitol. 1988 Dec;39(4):273-6
60f. Ribose metabolism and nucleic acid synthesis in normal
and glucose-6-phosphate dehydrogenase-deficient human
erythrocytes infected with Plasmodium falciparum.
Roth EF Jr, Ruprecht RM, Schulman S, Vanderberg J, Olson JA
J Clin Invest. 1986 Apr;77(4):1129-35
60g. The effect of X chromosome inactivation on the
inhibition of Plasmodium falciparum malaria growth
by glucose-6-phosphate-dehydrogenase-deficient red cells.
Roth EF Jr, Raventos Suarez C, Rinaldi A, Nagel RL
Blood. 1983 Oct;62(4):866-8
60h. Excess release of ferriheme in G6PD-deficient
erythrocytes: possible cause of hemolysis and
resistance to malaria.
Janney SK, Joist JJ, Fitch CD
Blood. 1986 Feb;67(2):331-3
60i. Susceptibility to hydrogen peroxide of Plasmodium falciparum
infecting glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Kamchonwongpaisan S, Bunyaratvej A, Wanachiwanawin W, Yuthavong Y
Parasitology. 1989 Oct;99 Pt 2:171-4
61a. Denaturation of Protein by Chlorine Dioxide:
Oxidative Modification of Tryptophan and Tyrosine Residues.
Ogata N
Biochemistry. 2007 Mar 31
61b. Chlorate poisoning: mechanism of toxicity.
Steffen C, Wetzel E
Toxicology. 1993 Nov 12;84(1-3):217-31
61c. Erythrocyte membrane alterations as the basis
of chlorate toxicity.
Singelmann E, Wetzel E, Adler G, Steffen C
Toxicology. 1984 Mar;30(2):135-47
61d. Chlorate poisoning: mechanism of toxicity.
Steffen C, Wetzel E
Toxicology. 1993 Nov 12;84(1-3):217-31
61e. Inorganic Chemistry An Advanced Textbook.
Moeller T
p 440
John Wiley & Sons, Inc.
62a. The impact of ferrous ion reduction of chlorite ion
on drinking water process performance.
Henderson R, Carlson K, Gregory D
Water Res. 2001 Dec;35(18):4464-73
62b. Removal of chlorine dioxide disinfection
by-products by ferrous salts.
Katz A, Narkis N
Water Res. 2001 Jan;35(1):101-8
62c. Chlorine dioxide reduction by aqueous iron(II) through
outer-sphere and inner-sphere electron-transfer pathways.
Wang L, Odeh IN, Margerum DW
Inorg Chem. 2004 Nov 15;43(23):7545-51
62d. Electrochemical metalloporphyrin-catalyzed reduction
of chlorite.
Collman JP, Boulatov R, Sunderland CJ, Shiryaeva IM,
Berg KE
J Am Chem Soc. 2002 Sep 11;124(36):10670-1
63a. Potency ranking of methemoglobin-forming agents.
French CL, Yaun SS, Baldwin LA, Leonard DA, Zhao XQ,
Calabrese EJ
J Appl Toxicol. 1995 May-Jun;15(3):167-74
63b. Theoretical mechanistic basis of oxidants
of methaemoglobin formation.
Akintonwa DA
Med Hypotheses. 2000 Feb;54(2):312-20
64a. Design, synthesis and antimalarial activity
of a new class of iron chelators.
Solomon VR, Haq W, Puri SK, Srivastava K, Katti SB
Med Chem. 2006 Mar;2(2):133-8
64b. Heme biosynthesis by the malarial parasite.
Import of delta-aminolevulinate dehydrase
from the host red cell.
Bonday ZQ, Taketani S, Gupta PD, Padmanaban G
J Biol Chem. 1997 Aug 29;272(35):21839-46
64c. Hemoglobin catabolism and iron utilization
by malaria parasites.
Rosenthal PJ, Meshnick SR
Mol Biochem Parasitol. 1996 Dec 20;83(2):131-9
64d. Heme metabolism of Plasmodium is a major
antimalarial target.
Padmanaban G, Rangarajan PN
Biochem Biophys Res Commun. 2000 Feb 24;268(3):665-8
64e. Iron chelators: mode of action as antimalarials.
Cabantchik ZI, Glickstein H, Golenser J, Loyevsky M,
Tsafack A
Acta Haematol. 1996;95(1):70-7
64f. The reaction of chloroperoxidase with chlorite
and chlorine dioxide.
Shahangian S, Hager LP
J Biol Chem. 1981 Jun 25;256(12):6034-40
65a. The plant-type ferredoxin-NADP+ reductase/ferredoxin
redox system as a possible drug target against apicomplexan
human parasites.
Seeber F, Aliverti A, Zanetti G
Curr Pharm Des. 2005;11(24):3159-72
65b. Ferredoxin-NADP(+) Reductase from Plasmodium falciparum
Undergoes NADP(+)-dependent Dimerization and Inactivation:
Functional and Crystallographic Analysis.
Milani M, Balconi E, Aliverti A, Mastrangelo E, Seeber F,
Bolognesi M, Zanetti G
J Mol Biol. 2007 Mar 23;367(2):501-13
65c. Cloning and Characterization of Ferredoxin and
Ferredoxin-NADP+ Reductase from Human Malaria Parasite.
Kimata-Ariga Y, Kurisu G, Kusunoki M, Aoki S, Sato D,
Kobayashi T, Kita K, Horii T, Hase T
J Biochem (Tokyo). 2007 Mar;141(3):421-428;Epub 2007 Jan 23
65d. Reconstitution of an apicoplast-localised electron
transfer pathway involved in the isoprenoid
biosynthesis of Plasmodium falciparum.
Röhrich RC, Englert N, Troschke K, Reichenberg A, Hintz M,
Seeber F, Balconi E, Aliverti A, Zanetti G, Köhler U,
Pfeiffer M, Beck E, Jomaa H, Wiesner J
FEBS Lett. 2005 Nov 21;579(28):6433-8;Epub 2005 Nov 02
65e. The plant-type ferredoxin-NADP+ reductase/ferredoxin redox
system as a possible drug target against apicomplexan human
parasites.
Seeber F, Aliverti A, Zanetti G
Curr Pharm Des. 2005;11(24):3159-72
65f. Biogenesis of iron-sulphur clusters
in amitochondriate and apicomplexan protists.
Seeber F
Int J Parasitol. 2002 Sep;32(10):1207-17
65g. Apicomplexan parasites possess distinct nuclear-encoded,
but apicoplast-localized, plant-type ferredoxin-NADP+
reductase and ferredoxin.
Vollmer M, Thomsen N, Wiek S, Seeber F
J Biol Chem. 2001 Feb 23;276(8):5483-90;Epub 2000 Oct 30
66a. Superoxide dismutase as a target enzyme
for Fe-porphyrin-induced cell death.
Asayama S, Kasugai N, Kubota S, Nagaoka S, Kawakami H
J Inorg Biochem. 2007 Feb;101(2):261-6
66b. The crystal structure of superoxide dismutase
from Plasmodium falciparum.
Boucher IW, Brzozowski AM, Brannigan JA, Schnick C,
Smith DJ, Kyes SA, Wilkinson AJ
BMC Struct Biol. 2006;6:20
66c. Identification of a mitochondrial superoxide dismutase
with an unusual targeting sequence in Plasmodium falciparum.
Sienkiewicz N, Daher W, Dive D, Wrenger C, Viscogliosi E,
Wintjens R, Jouin H, Capron M, Müller S, Khalife J
Mol Biochem Parasitol. 2004 Sep;137(1):121-32
66d. Oxidative stress and antioxidant defenses:
a target for the treatment of diseases caused
by parasitic protozoa.
Turrens JF
Mol Aspects Med. 2004 Feb-Apr;25(1-2):211-20
66e. Screening of Plasmodium falciparum iron superoxide
dismutase inhibitors and accuracy of the SOD-assays.
Soulère L, Delplace P, Davioud-Charvet E, Py S,
Sergheraert C, Périé J, Ricard I, Hoffmann P, Dive D
Bioorg Med Chem. 2003 Nov 17;11(23):4941-4
66f. Superoxide dismutase in Plasmodium: a current survey.
Dive D, Gratepanche S, Yera H, Bécuwe P, Daher W,
Delplace P, Odberg-Ferragut C, Capron M, Khalife J
Redox Rep. 2003;8(5):265-7
66g. Biochemical and electron paramagnetic resonance study
of the iron superoxide dismutase from Plasmodium falciparum.
Gratepanche S, Ménage S, Touati D, Wintjens R, Delplace P,
Fontecave M, Masset A, Camus D, Dive D
Mol Biochem Parasitol. 2002 Apr 9;120(2):237-46
66h. Cloning and characterization of iron-containing
superoxide dismutase from the human malaria species
Plasmodium ovale, P. malariae and P. vivax.
Baert CB, Deloron P, Viscogliosi E, Delgado-Viscogliosi P,
Camus D, Dive D
Parasitol Res. 1999 Dec;85(12):1018-24
66i. The role of superoxide dismutation in malaria parasites.
Schwartz E, Samuni A, Friedman I, Hempelmann E, Golenser J
Inflammation. 1999 Aug;23(4):361-70
66j. Characterization of iron-dependent endogenous
superoxide dismutase of Plasmodium falciparum.
Bécuwe P, Gratepanche S, Fourmaux MN, Van Beeumen J,
Samyn B, Mercereau-Puijalon O, Touzel JP, Slomianny C,
Camus D, Dive D
Mol Biochem Parasitol. 1996 Feb-Mar;76(1-2):125-34
66k. Subcellular distribution of superoxide dismutase and
catalase in human malarial parasite Plasmodium vivax.
Sharma A
Indian J Exp Biol. 1993 Mar;31(3):275-7
66L. Presence of an endogenous superoxide dismutase
activity in three rodent malaria species.
Bécuwe P, Slomianny C, Camus D, Dive D
Parasitol Res. 1993;79(5):349-52
66m. Oxidant defense enzymes of Plasmodium falciparum.
Fairfield AS, Abosch A, Ranz A, Eaton JW, Meshnick SR
Mol Biochem Parasitol. 1988 Jul;30(1):77-82
67a. Structural metal dependency of the arginase
from the human malaria parasite Plasmodium falciparum.
Müller IB, Walter RD, Wrenger C
Biol Chem. 2005 Feb;386(2):117-26
68a. Targeting enzymes involved in spermidine metabolism
of parasitic protozoa--a possible new strategy
for anti-parasitic treatment.
Kaiser A, Gottwald A, Maier W, Seitz HM
Parasitol Res. 2003 Dec;91(6):508-16
68b. Cellular polyamine profile of the phyla Dinophyta,
Apicomplexa, Ciliophora, Euglenozoa, Cercozoa and
Heterokonta.
Hamana K, Sakamoto A, Nishina M, Niitsu M
J Gen Appl Microbiol. 2004 Oct;50(5):297-303
68c. Diamine derivatives with antiparasitic activities.
Labadie GR, Choi SR, Avery MA
Bioorg Med Chem Lett. 2004 Feb 9;14(3):615-9
68d. Spermidine metabolism in parasitic protozoa--
a comparison to the situation in prokaryotes, viruses,
plants and fungi.
Kaiser AE, Gottwald AM, Wiersch CS, Maier WA, Seitz HM
Folia Parasitol (Praha). 2003 Mar;50(1):3-18
69a. Polyamines in the cell cycle of the malarial parasite
Plasmodium falciparum.
Bachrach U, Abu-Elheiga L, Assaraf YG, Golenser J, Spira DT
Adv Exp Med Biol. 1988;250:643-50
69b. Polyamine synthesis and salvage pathways
in the malaria parasite Plasmodium falciparum.
Ramya TN, Surolia N, Surolia A
Biochem Biophys Res Commun. 2006 Sep 22;348(2):579-84
69c. The spermidine synthase of the malaria parasite
Plasmodium falciparum: molecular and biochemical
characterisation of the polyamine synthesis enzyme.
Haider N, Eschbach ML, Dias Sde S, Gilberger TW, Walter RD,
Lüersen K
Mol Biochem Parasitol. 2005 Aug;142(2):224-36
69d. Targeting malaria with polyamines.
Geall AJ, Baugh JA, Loyevsky M, Gordeuk VR, Al-Abed Y,
Bucala R
Bioconjug Chem. 2004 Nov-Dec;15(6):1161-5
69e. The Plasmodium falciparum bifunctional ornithine
decarboxylase, S-adenosyl-L-methionine decarboxylase,
enables a well balanced polyamine synthesis without
domain-domain interaction.
Wrenger C, Luersen K, Krause T, Muller S, Walter RD
J Biol Chem. 2001 Aug 10;276(32):29651-6
69f. Effect of polyamines on the activity of malarial
alpha-like DNA polymerase.
Bachrach U, Abu-Elheiga L
Eur J Biochem. 1990 Aug 17;191(3):633-7
69g. Plasmodium falciparum: purification, properties,
and immunochemical study of ornithine decarboxylase,
the key enzyme in polyamine biosynthesis.
Assaraf YG, Kahana C, Spira DT, Bachrach U
Exp Parasitol. 1988 Oct;67(1):20-30
69h. Polyamines in the cell cycle of the malarial parasite
Plasmodium falciparum.
Bachrach U, Abu-Elheiga L, Assaraf YG, Golenser J,
Spira DT
Adv Exp Med Biol. 1988;250:643-50
69i. Effect of polyamine depletion on macromolecular
synthesis of the malarial parasite, Plasmodium
falciparum, cultured in human erythrocytes.
Assaraf YG, Abu-Elheiga L, Spira DT, Desser H, Bachrach U
Biochem J. 1987 Feb 15;242(1):221-6
69j. Polyamine levels and the activity of their
biosynthetic enzymes in human erythrocytes infected
with the malarial parasite, Plasmodium falciparum.
Assaraf YG, Golenser J, Spira DT, Bachrach U
Biochem J. 1984 Sep 15;222(3):815-9
69k. Plasmodium berghei: inhibitors of ornithine
decarboxylase block exoerythrocytic schizogony.
Hollingdale MR, McCann PP, Sjoerdsma A
Exp Parasitol. 1985 Aug;60(1):111-7
70a. 3-Aminooxy-1-aminopropane and derivatives have an
antiproliferative effect on cultured Plasmodium falciparum
by decreasing intracellular polyamine concentrations.
Das Gupta R, Krause-Ihle T, Bergmann B, Müller IB,
Khomutov AR, Müller S, Walter RD, Lüersen K
Antimicrob Agents Chemother. 2005 Jul;49(7):2857-64
70b. Antimalarial effect of agmatine on Plasmodium
berghei K173 strain.
Su RB, Wei XL, Liu Y, Li J
Acta Pharmacol Sin. 2003 Sep;24(9):918-22
70c. Antiplasmodial activity of a series of
1,3,5-triazine-substituted polyamines.
Klenke B, Barrett MP, Brun R, Gilbert IH
J Antimicrob Chemother. 2003 Aug;52(2):290-3
70d. Effect of drugs inhibiting spermidine biosynthesis
and metabolism on the in vitro development of Plasmodium
falciparum.
Kaiser A, Gottwald A, Wiersch C, Lindenthal B, Maier W,
Seitz HM
Parasitol Res. 2001 Nov;87(11):963-72
70e. Polyamine metabolism in various tissues during
pathogenesis of chloroquine-susceptible and resistant
malaria.
Mishra M, Chandra S, Pandey VC, Tekwani BL
Cell Biochem Funct. 1997 Dec;15(4):229-35
70f. Combined action of inhibitors of S-adenosylmethionine
decarboxylase with an antimalarial drug, chloroquine,
on Plasmodium falciparum.
Das B, Gupta R, Madhubala R
J Eukaryot Microbiol. 1997 Jan-Feb;44(1):12-7
70g. Combined action of inhibitors of polyamine biosynthetic
pathway with a known antimalarial drug chloroquine on
Plasmodium falciparum.
Das B, Gupta R, Madhubala R
Pharmacol Res. 1995 Mar-Apr;31(3-4):189-93
70h. Irreversible inhibition of S-adenosylmethionine
decarboxylase in Plasmodium falciparum-infected
erythrocytes: growth inhibition in vitro.
Wright PS, Byers TL, Cross-Doersen DE, McCann PP,
Bitonti AJ
Biochem Pharmacol. 1991 Jun 1;41(11):1713-8
70i. Antimalarial polyamine analogues.
Edwards ML, Stemerick DM, Bitonti AJ, Dumont JA,
McCann PP, Bey P, Sjoerdsma A
J Med Chem. 1991 Feb;34(2):569-74
70j. Plasmodium falciparum and Plasmodium berghei:
effects of ornithine decarboxylase inhibitors
on erythrocytic schizogony.
Bitonti AJ, McCann PP, Sjoerdsma A
Exp Parasitol. 1987 Oct;64(2):237-43
70k. Ornithine decarboxylase of Plasmodium falciparum:
a peak-function enzyme and its inhibition by chloroquine.
Königk E, Putfarken B
Trop Med Parasitol. 1985 Jun;36(2):81-4
70L. Ornithine decarboxylase inhibition and
the malaria-infected red cell:
a model for polyamine metabolism and growth.
Whaun JM, Brown ND
J Pharmacol Exp Ther. 1985 May;233(2):507-11
71a. Polyamine oxidase in human retroplacental serum
inhibits the growth of Plasmodium falciparum.
Egan JE, Haynes JD, Brown ND, Eisemann CS
Am J Trop Med Hyg. 1986 Sep;35(5):890-7
71b. The effect of purified aminoaldehydes produced
by polyamine oxidation on the development in vitro
of Plasmodium falciparum in normal and
glucose-6-phosphate-dehydrogenase-deficient erythrocytes.
Morgan DM, Bachrach U, Assaraf YG, Harari E, Golenser J
Biochem J. 1986 May 15;236(1):97-101
71c. Polyamine oxidase-mediated intraerythrocytic
killing of Plasmodium falciparum: evidence against
the role of reactive oxygen metabolites.
Rzepczyk CM, Saul AJ, Ferrante A
Infect Immun. 1984 Jan;43(1):238-44
71d. Polyamine oxidase mediates intra-erythrocytic
death of Plasmodium falciparum.
Ferrante A, Rzepczyk CM, Allison AC
Trans R Soc Trop Med Hyg. 1983;77(6):789-91
71e. Reactive oxygen and nitrogen intermediates and products
from polyamine degradation are Babesiacidal in vitro.
Johnson WC, Cluff CW, Goff WL, Wyatt CR
Ann N Y Acad Sci. 1996 Jul 23;791:136-47
72a. Chlorine Dioxide: Chemical and Physical Properties.
Rosenblatt DH, pp 332-343, 338
Products of Chlorine Dioxide Treatment of Organic Materials
in Water.
Stevens AA, pp 383-395, 388
Ozone/Chlorine Dioxide Oxidation Products of Organic Materials.
Rice RG, Cotruvo JA editors,
International Ozone Institute & USEPA,
Ozone Press International, 1978
73a. Chlorine dioxide oxidation of guanosine 5'-monophosphate.
Napolitano MJ, Stewart DJ, Margerum DW
Chem Res Toxicol. 2006 Nov;19(11):1451-8
74a. Transfer of purines from liver to erythrocytes.
In vivo and in vitro studies.
Konishi Y, Ichihara A
J Biochem (Tokyo). 1979 Jan;85(1):295-301
75a. Nucleoside transport as a potential target
for chemotherapy in malaria.
Baldwin SA, McConkey GA, Cass CE, Young JD
Curr Pharm Des. 2007;13(6):569-80
75b. Xanthine oxidase inhibits growth of Plasmodium
falciparum in human erythrocytes in vitro.
Berman PA, Human L, Freese JA
J Clin Invest. 1991 Dec;88(6):1848-55
75c. Hypoxanthine depletion induced by xanthine oxidase
inhibits malaria parasite growth in vitro.
Berman PA, Human L
Adv Exp Med Biol. 1991;309A:165-8
76a. Molecules targeting the purine salvage pathway
in Apicomplexan parasites.
Ghérardi A, Sarciron ME
Trends Parasitol. 2007 Aug;23(8):384-9
76b. Nucleoside transport as a potential target
for chemotherapy in malaria.
Baldwin SA, McConkey GA, Cass CE, Young JD
Curr Pharm Des. 2007;13(6):569-80
76c. The plasma membrane permease PfNT1 is essential
for purine salvage in the human malaria parasite
Plasmodium falciparum.
El Bissati K, Zufferey R, Witola WH, Carter NS, Ullman B,
Ben Mamoun C
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9286-91
76d. Purine metabolism by the avian malarial parasite
Plasmodium lophurae.
Yamada KA, Sherman IW
Mol Biochem Parasitol. 1981 Aug;3(4):253-64
76e. Purine metabolism during continuous erythrocyte
culture of human malaria parasites (P. falciparum).
Webster HK, Whaun JM
Prog Clin Biol Res. 1981;55:557-73
76f. Purine base and nucleoside uptake
in Plasmodium berghei and host erythrocytes.
Hansen BD, Sleeman HK, Pappas PW
J Parasitol. 1980 Apr;66(2):205-12
76g. Comparison of tritiated hypoxanthine, adenine and
adenosine for purine-salvage incorporation into nucleic
acids of the malarial parasite, Plasmodium berghei.
Van Dyke K
Tropenmed Parasitol. 1975 Jun;26(2):232-8
76h. Purine uptake and utilization by the avian malaria
parasite Plasmodium lophurae.
Tracy SM, Sherman IW
J Protozool. 1972 Aug;19(3):541-9
76i. [Incorporation of exogenous adenosine and
hypoxanthine in the nucleic acids of malaria parasites
(Plasmodium berghei and Plasmodium vinckei)]
Büngener W
Z Parasitenkd. 1968;31(1):1 [Article in German]
77a. Targeting purine and pyrimidine metabolism in human
apicomplexan parasites.
Hyde JE
Curr Drug Targets. 2007 Jan;8(1):31-47
77b. Purine-less death in Plasmodium falciparum induced
by immucillin-H, a transition state analogue
of purine nucleoside phosphorylase.
Kicska GA, Tyler PC, Evans GB, Furneaux RH, Schramm VL,
Kim K
J Biol Chem. 2002 Feb 1;277(5):3226-31
77c. Structure-activity relationships and inhibitory effects
of various purine derivatives on the in vitro growth of
Plasmodium falciparum.
Harmse L, van Zyl R, Gray N, Schultz P, Leclerc S,
Meijer L, Doerig C, Havlik I
Biochem Pharmacol. 2001 Aug 1;62(3):341-8
77d. In vitro susceptibilities of Plasmodium falciparum
to compounds which inhibit nucleotide metabolism.
Queen SA, Jagt DL, Reyes P
Antimicrob Agents Chemother. 1990 Jul;34(7):1393-8
77e. Synthesis of adenosine nucleotides from hypoxanthine
by human malaria parasites (Plasmodium falciparum)
in continuous erythrocyte culture:
inhibition by hadacidin but not alanosine.
Webster HK, Whaun JM, Walker MD, Bean TL
Biochem Pharmacol. 1984 May 1;33(9):1555-7
77f. Hypoxanthine metabolism by human malaria
infected erythrocytes: focus for the design
of new antimalarial drugs.
Webster HK, Wiesmann WP, Walker MD, Bean T, Whaun JM
Adv Exp Med Biol. 1984;165 Pt A:219-23
77g. Antimalarial properties of bredinin.
Prediction based on identification of differences
in human host-parasite purine metabolism.
Webster HK, Whaun JM
J Clin Invest. 1982 Aug;70(2):461-9
78a. Denaturation of Protein by Chlorine Dioxide:
Oxidative Modification of Tryptophan and Tyrosine Residues.
Ogata N
Biochemistry. 2007 Mar 31
78b. Chlorine dioxide oxidations of tyrosine,
N-acetyltyrosine, and dopa.
Napolitano MJ, Green BJ, Nicoson JS, Margerum DW
Chem Res Toxicol. 2005 Mar;18(3):501-8
78c. Reaction of chlorine dioxide with amino acids
and peptides: kinetics and mutagenicity studies.
Tan HK, Wheeler WB, Wei CI
Mutat Res. 1987 Aug;188(4):259-66
78d. Reactions of aqueous chlorine dioxide
with amino acids found in water.
Taymaz K, Williams DT, Benoit FF
Bull Environ Contam Toxicol. 1979 Nov;23(4-5):456-63
79a. Controlled clinical evaluations of chlorine dioxide,
chlorite and chlorate in man.
Lubbers JR, Chauan S, Bianchine JR
Environ Health Perspect. 1982 Dec;46:57-62
79b. Toxicological Review of Chlorine Dioxide and Chlorite.
Integrated Risk Information System,
EPA/635/R-00/007, September 2000
79c. Toxicological Profile for Chlorine Dioxide and Chlorite.
Agency for Toxic Substances and Disease Registry,
US Dept. Health and Human Services, September 2004
79d. Chlorite and chlorate in drinking-water. Background document
for preparation of WHO Guidelines for drinking-water quality.
WHO/SDE/WSH/03.04/86,
Geneva, World Health Organization, 2000
79e. Chlorine dioxide and hemodialysis.
Smith RP, Willhite CC
Regul Toxicol Pharmacol. 1990 Feb;11(1):42-62
79f. Effect of chlorine dioxide water disinfection on
hematologic and serum parameters of renal dialysis patients.
Ames RG, Stratton JW
Arch Environ Health. 1987 Sep-Oct;42(5):280-5
79g. The effects of chronic administration of chlorine dioxide,
chlorite and chlorate to normal healthy adult male volunteers.
Lubbers JR, Chauhan S, Miller JK, Bianchine JR
J Environ Pathol Toxicol Oncol. 1984 Jul;5(4-5):229-38
79h. Effects of the acute rising dose administration
of chlorine dioxide, chlorate and chlorite to normal
healthy adult male volunteers.
Lubbers JR, Bianchine JR.
J Environ Pathol Toxicol Oncol. 1984 Jul;5(4-5):215-28
79i. Controlled clinical evaluations of chlorine dioxide,
chlorite and chlorate in man.
Lubbers JR, Chauhan S, Bianchine JR
Fundam Appl Toxicol. 1981 Jul-Aug;1(4):334-8
79j. Acute and chronic toxicity of chlorine dioxide (ClO2)
and chlorite (ClO2-) to rainbow trout (Oncorhynchus mykiss).
Svecevicius G, Syvokiene J, Stasiunaite P, Mickeniene L
Environ Sci Pollut Res Int. 2005 Sep;12(5):302-5
80a. The effects of chlorine dioxide and sodium chlorite
on erythrocytes of A/J and C57L/J mice.
Moore GS, Calabrese EJ
J Environ Pathol Toxicol. 1980 Sep;4(2-3):513-24
80b. Subchronic toxicity of chlorine dioxide and related
compounds in drinking water in the nonhuman primate.
Bercz JP, Jones L, Garner L, Murray D, Ludwig DA, Boston J
Environ Health Perspect. 1982 Dec;46:47-55
80c. Oxidative damage to the erythrocyte induced
by sodium chlorite, in vivo.
Heffernan WP, Guion C, Bull RJ
J Environ Pathol Toxicol. 1979 Jul-Aug;2(6):1487-99
80d. Acute and chronic toxicity of chlorine dioxide (ClO2)
and chlorite (ClO2-) to rainbow trout (Oncorhynchus mykiss).
Svecevicius G, Syvokiene J, StasiÅnaite P, Mickeniene L
Environ Sci Pollut Res Int. 2005 Sep;12(5):302-5
80e. The kinetics of chlorite and chlorate in rats.
Abdel-Rahman MS, Couri D, Bull RJ
J Environ Pathol Toxicol Oncol. 1985 Sep-Oct;6(1):97-103
80f. Teratologic evaluation of Alcide liquid
in rats and mice. I.
Skowronski GA, Abdel-Rahman MS, Gerges SE, Klein KM
J Appl Toxicol. 1985 Apr;5(2):97-103
80g. Effects of Alcide gel on fetal development
in rats and mice. II.
Gerges SE, Abdel-Rahman MS, Skowronski GA, Von Hagen S
J Appl Toxicol. 1985 Apr;5(2):104-9
80h. Biochemical interactions of chlorine dioxide
and its metabolites in rats.
Suh DH, Abdel-Rahman MS, Bull RJ
Arch Environ Contam Toxicol. 1984 Mar;13(2):163-9
80i. Pharmacokinetics of Alcide, a germicidal compound in rat.
Scatina J, Abdel-Rahman MS, Gerges SE, Alliger H
J Appl Toxicol. 1983 Jun;3(3):150-3
80j. Effect of chlorine dioxide and its metabolites
in drinking water on fetal development in rats.
Suh DH, Abdel-Rahman MS, Bull RJ
J Appl Toxicol. 1983 Apr;3(2):75-9
80k. Metabolism and pharmacokinetics
of alternate drinking water disinfectants.
Abdel-Rahman MS, Couri D, Bull RJ
Environ Health Perspect. 1982 Dec;46:19-23
80L. Toxicological effects of chlorine dioxide, chlorite
and chlorate.
Couri D, Abdel-Rahman MS, Bull RJ
Environ Health Perspect. 1982 Dec;46:13-7
80m. Toxicological effects of chlorite in the mouse.
Moore GS, Calabrese EJ
Environ Health Perspect. 1982 Dec;46:31-7
80n. Chlorine dioxide metabolism in rat.
Abdel-Rahman MS, Couri D, Jones JD
J Environ Pathol Toxicol. 1979 Dec;3(1-2):421-30
80o. Toxicity of chlorine dioxide in drinking water.
Abdel-Rahman MS, Couri D, Bull RJ
J Environ Pathol Toxicol Oncol. 1985 Sep-Oct;6(1):105-13
80p. Sodium chlorite. IARC monographs on the evaluation
of carcinogenic risks to human. (1991) 52:145-58
80q. Study on subchronic toxicity of chlorine dioxide
and by-products in water.
Qingdong X, Guangming Z, Li W
J Environ Sci Health A Tox Hazard Subst Environ Eng.
2006;41(7):1347-53
80r. Effects of chlorine dioxide on the developing rat brain.
Toth GP, Long RE, Mills TS, Smith MK
J Toxicol Environ Health. 1990 Sep;31(1):29-44
80s. Subchronic dermal toxicity studies of Alcide Allay gel
and liquid in rabbits.
Abdel-Rahman MS, Skowronski GA, Turkall RM, Gerges SE,
Kadry AR, Abu-Hadeed AH
J Appl Toxicol. 1987 Oct;7(5):327-33
80t. Effects of chlorine dioxide on thyroid function
in the African green monkey and the rat.
Harrington RM, Shertzer HG, Bercz JP
J Toxicol Environ Health. 1986;19(2):235-42
81a. Acute sodium chlorite poisoning associated
with renal failure.
Lin JL, Lim PS
Ren Fail. 1993;15(5):645-8
82a. First-aid reports of acute chlorine gassing among
pulpmill workers as predictors of lung health consequences.
SALISBURY DA, ENARSON DA, CHAN-YEUNG M, KENNEDY SM
Dep. Med., Respiratory Div., Univ. B.C., 2775 Heather St.,
Vancouver, B.C. V5Z 3J5, Canada
AM J IND MED; (1991) 20(1):71-82
82b. Health Effects of Working in Pulp and Paper Mills:
Exposure, Obstructive Airways Diseases,
Hypersensitivity Reactions, and Cardiovascular Diseases.
Toren K, Hagberg S, Westberg H
American Journal of Industrial Medicine, 29(2):111-122,
75 references, 1996.
82c. Reactive Airways Dysfunction Syndrome Due
to Chlorine [Dioxide]: Sequential Bronchial Biopsies
and Functional Assessment
Lemiere C, Malo J-L, Boutet M
European Respiratory Journal, 1997, 10(1):241-244,
82d. Chlorine Dioxide [regarding gas exposure]
Concise International Chemical Assessment Document (CICAD)
Volume 37 (2002) 20 pages
82e. Chlorine Dioxide. HSE. Risk assessment document.
Volume EH72/14 (2000) 61 pages. Occupational exposure.
82f. Respiratory effects of industrial chlorine and
chlorine dioxide exposure. [academic dissertation]
Grenquist-Nordâen B Institute of Occupational Health,
University of Helsinki, Haartmaninkatu 1, Helsinki, Finland,
1983, 83pages
82g. Chlorine dioxide.
Commission of the European Communities, 2920 Luxembourg,
Grand Duchy of Luxembourg; International Programme
on Chemical Safety (IPCS), World Health Organization,
1211 Genáeve 27, Switzerland, 1991, 2pages
83a. The effects of chronic administration of chlorite
to glucose-6-phosphate dehydrogenase deficient healthy
adult male volunteers.
Lubbers JR, Chauhan S, Miller JK, Bianchine JR
J Environ Pathol Toxicol Oncol. 1984 Jul;5(4-5):239-42
83b. G6PD-deficiency: a potential high-risk group
to copper and chlorite ingestion.
Moore GS, Calabrese EJ
J Environ Pathol Toxicol. 1980 Sep;4(2-3):271-9
83c. Groups at potentially high risk from chlorine dioxide
treated water.
Moore GS, Calabrese EJ, Ho SC
J Environ Pathol Toxicol. 1980 Sep;4(2-3):465-70
83d. G6PD-deficiency: a potential high-risk group
to copper and chlorite ingestion.
Moore GS, Calabrese EJ
J Environ Pathol Toxicol. 1980 Sep;4(2-3):271-9
83e. Potential health effects of chlorine dioxide
as a disinfectant in potable water supplies.
Moore GS, Calabrese EJ, DiNardi SR, Tuthill RW
Med Hypotheses. 1978 Sep-Oct;4(5):481-96
83f. [G6PD phenotype and red blood cell sensitivity
to the oxidising action of chlorites in drinking water]
Contu A, Bajorek M, Carlini M, Meloni P, Cocco P, Schintu M
Ann Ig. 2005 Nov-Dec;17(6):509-18 [Article in Italian]
83g. Effects of environmental oxidant stressors
on individuals with a G-6-PD deficiency with particular
reference to an animal model.
Calabrese EJ, Moore G, Brown R
Environ Health Perspect. 1979 Apr;29:49-55
84a. The effects of chronic administration of chlorite
to glucose-6-phosphate dehydrogenase deficient healthy
adult male volunteers.
Lubbers JR, Chauhan S, Miller JK, Bianchine JR
J Environ Pathol Toxicol Oncol. 1984 Jul;5(4-5):239-42
84b. [G6PD phenotype and red blood cell sensitivity
to the oxidising action of chlorites in drinking water]
Contu A, Bajorek M, Carlini M, Meloni P, Cocco P, Schintu M
Ann Ig. 2005 Nov-Dec;17(6):509-18 [Article in Italian]
85a. Estimation of the total parasite biomass in acute
falciparum malaria from plasma PfHRP2.
Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D,
Silamut K, Chotivanich K, Newton PN, Pitisuttithum P,
Smithyman AM, White NJ, Day NP
PLoS Med. 2005 Aug;2(8):e204;Epub 2005 Aug 23
Erratum in: PLoS Med. 2005 Oct;2(10):390
Comment in: PLoS Med. 2006 Jan;3(1):e68; Author reply e69.
86a. Current status and progresses made in malaria chemotherapy.
Liñares GE, Rodriguez JB
Curr Med Chem. 2007;14(3):289-314
87a. Toxoplasma gondii: the model apicomplexan.
Kim K, Weiss LM
Int J Parasitol. 2004 Mar 9;34(3):423-32
88a. Sequential inactivation of Cryptosporidium parvum
oocysts with chlorine dioxide followed by free chlorine
or monochloramine.
Corona-Vasquez B, Rennecker JL, Driedger AM, Mariñas BJ
Water Res. 2002 Jan;36(1):178-88
89a. Characterization of an omega-class glutathione-
S-transferase from Schistosoma mansoni with
glutaredoxin-like dehydroascorbate reductase and
thiol transferase activities.
Girardini J, Amirante A, Zemzoumi K, Serra E
Eur J Biochem. 2002 Nov;269(22):5512-21
89b. Thiol-based redox metabolism of protozoan parasites.
Muller S, Liebau E, Walter RD, Krauth-Siegel RL
Trends Parasitol. 2003 Jul;19(7):320-8
Comment in: Trends Parasitol. 2004 Feb;20(2):58-9
89c. The parasite-specific trypanothione metabolism
of trypanosoma and leishmania.
Krauth-Siegel RL, Meiering SK, Schmidt H
Biol Chem. 2003 Apr;384(4):539-49
89d. The synthesis of parasitic cysteine protease
and trypanothione reductase inhibitors.
Chibale K, Musonda CC
Curr Med Chem. 2003 Sep;10(18):1863-89
89e. Glutathione inhibits the antischistosomal activity
of artemether.
Zhai ZL, Jiao PY, Mei JY, Xiao SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi.
2002;20(4):212-5
89f. Schistosoma mansoni: expression and role of cysteine
proteinases in developing schistosomula.
Zerda KS, Dresden MH, Chappell CL
Exp Parasitol. 1988 Dec;67(2):238-46
89g. Mr 26,000 antigen of Schistosoma japonicum recognized
by resistant WEHI 129/J mice is a parasite glutathione
S-transferase.
Smith DB, Davern KM, Board PG, Tiu WU, Garcia EG, Mitchell GF
Proc Natl Acad Sci U S A. 1986 Nov;83(22):8703-7
Erratum in: Proc Natl Acad Sci U S A 1987 Sep;84(18):6541
89h. Oxidative stress and antioxidant defenses:
a target for the treatment of diseases caused
by parasitic protozoa.
Turrens JF
Mol Aspects Med. 2004 Feb-Apr;25(1-2):211-20
89i. Antioxidant defense mechanisms in parasitic protozoa.
Mehlotra RK
Crit Rev Microbiol. 1996;22(4):295-314
89j. Phenotypic analysis of trypanothione synthetase
knockdown in the African trypanosome.
Ariyanayagam MR, Oza SL, Guther ML, Fairlamb AH
Biochem J. 2005 Oct 15;391(Pt 2):425-32
89k. Gene knockdown of gamma-glutamylcysteine synthetase
by RNAi in the parasitic protozoa Trypanosoma brucei
demonstrates that it is an essential enzyme.
Huynh TT, Huynh VT, Harmon MA, Phillips MA
J Biol Chem. 2003 Oct 10;278(41):39794-800
89L. Polyamine and thiol metabolism in Trypanosoma
granulosum: similarities with Trypanosoma cruzi.
Mastri C, Thorborn DE, Davies AJ, Ariyanayagam MR,
Hunter KJ
Biochem Biophys Res Commun. 2001 Apr 20;282(5):1177-82
89m. Inducible resistance to oxidant stress
in the protozoan Leishmania chagasi.
Miller MA, McGowan SE, Gantt KR, Champion M,
Novick SL, Andersen KA, Bacchi CJ, Yarlett N,
Britigan BE, Wilson ME
J Biol Chem. 2000 Oct 27;275(43):33883-9
89n. Pharmacological approaches to antitrypanosomal
chemotherapy.
Croft SL
Mem Inst Oswaldo Cruz. 1999 Mar-Apr;94(2):215-20
89o. Fate of soluble methionine in African trypanosomes:
effects of metabolic inhibitors.
Bacchi CJ, Goldberg B, Garofalo-Hannan J, Rattendi D,
Lyte P, Yarlett N
Biochem J. 1995 Aug 1;309 ( Pt 3):737-43
89p. In vivo effects of difluoromethylornithine
on trypanothione and polyamine levels
in bloodstream forms of Trypanosoma brucei.
Fairlamb AH, Henderson GB, Bacchi CJ, Cerami A
Mol Biochem Parasitol. 1987 Jun;24(2):185-91
90a. A Possible Solution to the Malaria Problem?
Humble J
Libertarian Times, May 9, 2005
90b. The Miracle Mineral Supplement of the 21st Century.
Humble JV
www.miraclemineral.org, 2nd Edition (2007)
Back to home page.
